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“The desire for cognitive enhancement is very strong, maybe
stronger than for beauty, or athletic ability.”
Benedict Carey1
I.

INTRODUCTION

Brains + drugs = fried eggs, right?2 Not always. Cognitive enhancers
are drugs designed to boost mental powers and stamina without turning your
brain into runny, white edibles.3 These enhancers affect the brain’s neural
processes that trigger memory, attention, learning, and decision making by
altering the balance of chemical neurotransmitters.4 While America’s
favorite cognitive enhancer is caffeine,5 other study drugs are the “highertech equivalents of NoDoz” or the two pots of coffee that students and
professionals otherwise consume to pull all-nighters for presentations, term
papers, or final exams.6 Such modern caffeine substitutes range from
stimulants to narcolepsy pills and are enticingly attractive for an overworked
twenty-four-seven society.7
In 2008, as cognitive enhancement increasingly became a household
name among scientists and academics, Henry Greely, Barbara Sahakian, and

1. Benedict Carey, Smartening Up: Brain Enhancement is Wrong, Right?, N.Y. TIMES (Mar. 9,
2008), http://www.nytimes.com/2008/03/09/weekinreview/09carey.html?_r=1&ref=todayspaper&
pagewanted=2 (quoting Dr. Barbara Sahakian of Cambridge University); see also infra notes 8–9
and accompanying text.
2. See Partnership for a Drug-Free America, Your Brain on Drugs, YOUTUBE (Sept. 16, 2008),
http://www.youtube.com/watch?v=3FtNm9CgA6U (depicting a well-known anti-drug commercial
from the 1980s). Drugs can be defined as any chemical agents that affect “living processes that may
be ingested through the mouth, the rectum, by injection, or by inhalation.” DAVID A. J. RICHARDS,
SEX, DRUGS, DEATH, AND THE LAW: AN ESSAY ON HUMAN RIGHTS AND OVERCRIMINALIZATION
158 (1982).
3. See Cognitive Enhancement, All on the Mind: Prepare for Drugs That Will Improve
Memory, Concentration and Learning, ECONOMIST, May 22, 2008, at 103 [hereinafter Cognitive
Enhancement, All on the Mind]; see also Joanne Chen, Can a Pill Make You Smarter? A Series of
New Drugs Promises to Increase Our Productivity and Focus, MARIE CLAIRE (Dec. 15, 2008),
http://www.marieclaire.com/career-money/jobs/pill-for-productivity-focus (referring to cognitive
enhancers as “[c]rack for nerds”).
4. Cognitive Enhancement, All on the Mind, supra note 3, at 103.
5. Karen J. Winkler, Pill-Popping Profs, CHRON. HIGHER EDUC., Jan. 11, 2008, at B4
(describing the demand for and daily use of caffeine as staggering despite its side effects and
addictive qualities).
6. Henry T. Greely, Remarks on Human Biological Enhancement, 56 U. KAN. L. REV. 1139,
1143–44 (2008) (discussing the future of cognitive enhancement).
7. Chen, supra note 3, at 169; see, e.g., Jason Kirby, Going to Work on Smart Drugs: Will
Employers Pressure Staff to Take Brain Boosters?, MACLEAN’S (Oct. 1, 2008),
http://www.macleans.ca/science/health/article.jsp?content=20081001_98115_98115 (interviewing
an aviation operations manager who takes narcolepsy medication as “part of a growing throng of
otherwise healthy individuals popping high-powered pharmaceuticals to add some zing to their grey
matter”).
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several of their colleagues aroused mainstream media attention8 when they
published a commentary in a prominent science journal that supported the
use of cognitive-enhancing medications as a way for healthy adults to boost
their mental capabilities.9 While they lobbied for general consumption by
society, they warned that certain settings warranted closer ethical scrutiny.10
Specifically, the authors mentioned the two most traditionally worrisome
categories for medicinal brain boosting—military personnel11 and school
children.12 Another area of concern, but one far less scrutinized, is the
higher-education setting of medical and law schools, where graduate
students intensely compete for grades in an environment designed to prepare
them for their professional responsibilities.13

8. See, e.g., Go Brain-Boosters, NEW SCIENTIST, Dec. 13, 2008, at 6; Ginger Rough,
Popularity of Brain-Boost Pills Drives Debate, ARIZ. REPUBLIC (July 5, 2009),
http://www.azcentral.com/arizonarepublic/news/articles/2009/07/05/20090705braindrugs0705.html;
Judith Warner, Living the Off-Label Life, N.Y. TIMES (Dec. 27, 2008), http://www.nytimes.com/
2008/12/27/opinion/27warner.html. George Annas, Chair of the Department of Health Law,
Bioethics, and Human Rights at Boston University, contended that Greely and his co-authors had
presented a rather idyllic view of cognitive enhancement that ignored the safety implications.
Bernadette Tansey, Experts Urge Wider Use of Brain-Boosting Drugs, S.F. CHRON. (Dec. 8, 2008),
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/12/07/MNHG14I85V.DTL. Annas questioned,
“[W]hat were they smoking when they wrote this article?” Id.
9. Henry Greely et al., Towards Responsible Use of Cognitive-Enhancing Drugs by the
Healthy, 456 NATURE 702, 702 (2008); see also Brain Boosters: How Should We Deal with
Cognitive-Enhancing Drugs?, STAN. MAG., Mar.–Apr. 2009, at 24, 25 [hereinafter Brain Boosters],
available at http://www.stanfordalumni.org/news/magazine/2009/marapr/farm/news/greely.html (in
a question-and-answer session, Professor Henry Greely argued that “[e]nhancement is not a dirty
word”).
10. Greely et al., supra note 9, at 703. Their ethical concerns centered on safety, freedom, and
fairness. Id. “[M]ore of this [is] coming down the road, and we’re just not prepared as a society yet
for how we should deal with good, safe, cognitively enhancing drugs that will almost certainly be
available in the next 10 to 20 years.” Brain Boosters, supra note 9, at 24.
11. See Greely et al., supra note 9, at 703; see also Catherine L. Annas & George J. Annas,
Enhancing the Fighting Force: Medical Research on American Soldiers, 25 J. CONTEMP. HEALTH L.
& POL’Y 283, 291 (2009).
12. See Greely et al., supra note 9, at 703; see also Ann Chiumino, Class Action Suits Prompt
Governmental Action to Examine Ritalin Use and Regulation, 13 LOY. CONSUMER L. REV. 380, 388
(2001). However, Greely also contended that scholastic cognitive-enhancement use that enhanced
long-term learning is acceptable in non-zero-sum school environments. Greely et al., supra note 9,
at 704.
13. See infra notes 16, 192–93 and accompanying text. Medicinal brain boosting in higher
education has barely generated any scrutiny or attention because medical and law school drug users
are “driven, healthy A-plus students,” not the traditional cocaine or alcohol abusers. See Nicholas
W. Schieffelin, Maintaining Educational and Athletic Integrity: How Will Schools Combat
Performance-Enhancing Drug Use?, 40 SUFFOLK U. L. REV. 959, 972 (2007). More importantly,
their drugs may be legal substances validly obtained through doctors’ prescriptions. Maxwell J.
Mehlman, Cognition-Enhancing Drugs, 82 MILBANK Q. 483, 492 (2004); see also infra notes 122–
24 and accompanying text.
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In this higher-education context, students who consume cognitive
enhancers may be like pupils who are allowed to use calculators on math
tests, while others are forced to struggle with paper and pen.14 Notably,
medical and law school students’ use of scholastic steroids generates more
ethical implications than the rest of society because these students labor
within unique ethical frameworks.15 Their prospective professions embrace
values that set them apart from the general public.16 These students and their
professional counterparts work under ethical codes and restrictions
promulgated by their respective national associations—the American
Medical Association (AMA) produces the Principles of Medical Ethics,17
and the American Bar Association (ABA) publicizes the Model Rules of
Professional Conduct.18 These codes govern students’ actions throughout
the entire educational process.19 First, applicants must demonstrate integrity

14. See Greely et al., supra note 9, at 703–04 (asking educators, academic admissions officers,
and credentials evaluators to ensure validity and integrity of examinations by formulating policies
addressing cognitive-enhancement drug use).
15. See Linda A. McGuire & Julie Phye, The Hidden Curriculum in Medical and Law Schools:
A Role for Student Affairs Professionals, 115 NEW DIRECTIONS STUDENT SERVICES 59, 63 (2006);
see also infra notes 16–19 and accompanying text.
16. McGuire & Phye, supra note 15, at 63 (explaining that doctors and lawyers are expected to
be contributors to the community and role models of service); see also SHAUN D. PATTINSON,
MEDICAL LAW AND ETHICS 2 (1st ed. 2006) (“Medical practice and the law regulating medical
practice play out in an overtly moral arena.”). In their education and employment, medical and law
school students aim for professionalism, a term used to describe “adherence to a set of values
beyond intellectual capacity that is common to the professions and gives practitioners the exclusive
right to engage in the profession’s activities.” McGuire & Phye, supra note 15, at 63.
Professionalism encompasses honor, integrity, accountability, altruism, and respect for others. Id. at
63, 65 (noting that medical and legal clinics permit students to practice hands-on professionalism).
The melding of professionalism and ethics into professional ethics forms guidelines on how to
integrate actions, commitments, and traits of character typical of the professions so as to acquire a
life well-lived. DANIEL MARKOVITS, A MODERN LEGAL ETHICS: ADVERSARY ADVOCACY IN A
DEMOCRATIC AGE 1 (2008).
17. See CODE OF MEDICAL ETHICS OF THE AMERICAN MEDICAL ASSOCIATION (2010). The
Code of Medical Ethics has been the “authoritative ethics guide for practicing physicians” for more
than 160 years. History of AMA Ethics, AM. MED. ASS’N, http://www.ama-assn.org/ama/pub/aboutama/our-history/history-ama-ethics.page (last visited Feb. 25, 2012) (providing a general history of
the Code of Medical Ethics); see also Principles of Medical Ethics, AM. MED. ASS’N,
http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/principlesmedical-ethics.page? (last visited Feb. 25, 2012) (tasking physicians to “uphold standards of
professionalism,” “respect the law,” and “regard responsibility to the patient as paramount”).
18. See MODEL RULES OF PROFESSIONAL CONDUCT (2010). The Model Rules of Professional
Conduct, which specifically requires lawyers to maintain the integrity of their profession, serves as a
model for the ethical rules of forty-nine states and the District of Columbia. See generally State
Adoption of the ABA Model Rules of Professional Conduct, AM. BAR ASS’N,
http://www.americanbar.org/groups/professional_responsibility/publications/model_rules_of_professio
nal_conduct/alpha_list_state_adopting_model_rules.html (last visited Feb. 25, 2012) (conspicuously,
California is absent from the list of states that have adopted the Model Rules).
19. See Elizabeth Gepford McCulley, School of Sharks? Bar Fitness Requirements of Good
Moral Character and the Role of Law Schools, 14 GEO. J. LEGAL ETHICS 839, 867 (2001)
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and adherence to ethical conduct when they apply to medical20 or law
schools.21 Second, once they officially become students, they must take
mandatory ethics or professional responsibility courses within their
medical22 or law school curriculum.23 After students graduate, entry into
their professional practices mandates that they pass licensure exams, as well
Finally, after achieving
as moral fitness and character inquiries.24
(suggesting methods to enforce ethical standards); see also infra notes 20–25 and accompanying
text.
20. ROBERT H. MILLER & DANIEL M. BISSELL, MED SCHOOL CONFIDENTIAL 74 (2006)
(discussing requirements for prospective medical students). For medical school applications, good
ethical conduct is usually assumed but, if an application reveals lapses in ethical conduct, the
applicant must specifically address this in a letter of explanation. Id. (“Any sort of criminal record,
especially one involving substance abuse, will be a matter of serious concern to admissions
committees.”). When medical students transfer to other medical schools, applications for transfer
should include a letter of evaluation from the current school’s Dean or Associate Dean of Student
Affairs that specifically addresses any infractions of the school’s code of ethical conduct. ASS’N OF
AM. MED. COLLS., HANDBOOK FOR ADMISSIONS OFFICERS 88 (GSA Nat’l Comm. on Admissions
Members eds., 2004).
21. See, e.g., LAW. SCH. ADMISSION COUNCIL & AM. BAR ASS’N, ABA-LSAC OFFICIAL GUIDE
TO ABA-APPROVED LAW SCHOOLS: 2012 EDITION 13–15 (2011). Law school applicants must
comply with the Law School Admission Council’s ethical standards—LSAC Rules Governing
Misconduct and Irregularities in the Admission Process—or face serious sanctions and possible
barring from the admission process. Id. (explaining that a later finding of misconduct may lead to
the closing of an admission file, the revocation of an offer of admission, dismissal from a law school,
or disbarment). Most law schools also inquire into applicants’ past criminal records on their
admission applications. Keith Swisher, The Troubling Rise of the Legal Profession’s Good Moral
Character, 82 ST. JOHN’S L. REV. 1037, 1044 (2008).
22. McGuire & Phye, supra note 15, at 64. In medical school, students also learn the
Hippocratic Oath, a declaration stating students and physicians’ intentions to practice medicine
justly and ethically. Raphael Hulkower, The History of the Hippocratic Oath: Outdated,
Inauthentic, and Yet Still Relevant, 25/26 EINSTEIN J. BIOLOGY & MED. 41, 41 (2010). Medical
students may actually first recite this oath after their new student orientation and before beginning
their formal education. McGuire & Phye, supra note 15, at 65 (explaining that such a procedure
alerts students to their professional responsibility for others’ well-being). Most medical students
also recite the oath during their graduation ceremonies. Hulkower, supra, at 41.
23. McCulley, supra note 19, at 862 (“The ABA requires accredited law schools to provide
education in the responsibilities of the legal profession as well as education covering the Model
Rules.”); see also PATTINSON, supra note 16, at 3 (noting that “morality is sometimes explicitly
incorporated into legal doctrine”). Law schools enforce ethical conduct with honor codes and ethics
committees. McCulley, supra note 19, at 858 (describing honor codes as promoting honesty,
integrity, and fairness). These honor codes are self-regulated and ask students to report suspected
violations. Id. at 858–60 (noting that some codes even allow sanctioning of witnesses who fail to
disclose infractions).
24. McGuire & Phye, supra note 15, at 63 (“[B]ecause lawyers and physicians take on the
responsibility for their clients’ or patients’ health, lives, livelihoods, and liberty, entry into
professional practice requires more than earning the terminal academic degree.”); see, e.g., Swisher,
supra note 21, at 1043 (noting that every state requires applicants to prove “good moral character”
before admission to the legal bar). Bar committees screen applicants by inquiring into conduct such
as illegal acts, academic misconduct, dishonesty, and drug abuse. McGuire & Phye, supra note 15,
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certification as physicians or lawyers, they “face lifelong regulation by
governmental and professional entities and, in many areas, a requirement of
annual continuing education.”25
Because medical and law schools are such ethically-governed settings,
the fundamental question then becomes whether scholastic use of cognitiveenhancement medications is actually a form of cheating.26 If answered
affirmatively, this question requires action from the AMA, ABA, and
respective educational institutions for the formulation of ethical guidelines
and policies that would address and limit such cheating.27 This Comment
attempts to answer whether medicinal brain boosting within medical and law
schools is cognitive cheating by addressing the issue through pertinent
ethical concerns.
Part II of this Comment provides a scientific overview of the four most
common cognitive enhancers and their FDA-approved uses.28 Part II also
discusses the off-label exploitation of these medications.29 Part III analyzes
medicinal neurocognitive enhancement within medical and law schools
through three ethical categories—safety concerns, social implications, and
fairness issues—to determine if such use is cognitive cheating.30 Part IV
presents possible steps that university administrators may implement to
prevent or monitor consumption of cognitive enhancers.31 Part IV further
suggests new AMA and ABA guidelines that would directly address this
issue.32 Part V concludes.33
II. POPPING SMART PILLS: USE AND ABUSE OF COGNITIVE ENHANCERS
The question of whether medicinal cognitive enhancement is cheating in
a higher-educational environment requires understanding both the science
behind cognitive enhancers and their resulting uses. This Comment will
at 63. For example, prospective lawyers must meet standards of fitness and demonstrate moral
traits—including honesty, responsibility, and truthfulness. McCulley, supra note 19, at 842, 850
(explaining that one highly offensive act or pattern of minor offensive behavior can cause denial of
admission to the state legal bar). In most jurisdictions, they also must take and pass the Multistate
Professional Responsibility Examination. Bar Admissions Basic Overview, AM. BAR ASS’N,
http://www.americanbar.org/groups/legal_education/resources/bar_admissions/basic_overview.html
(last visited Feb. 25, 2012).
25. McGuire & Phye, supra note 15, at 63.
26. See infra notes 114–16 and accompanying text. Cheating may be defined as an intentional
violation of an explicit or implicit rule to gain an unfair advantage over others. See M. Schermer,
On the Argument that Enhancement Is “Cheating,” 34 J. MED. ETHICS 85, 85 (2008).
27. See infra notes 291–92 and accompanying text.
28. See infra notes 34–67 and accompanying text.
29. See infra notes 70–111 and accompanying text.
30. See infra notes 116–287 and accompanying text.
31. See infra notes 290–364 and accompanying text.
32. See infra notes 367–86 and accompanying text.
33. See infra notes 387–92 and accompanying text.

994

DO NOT DELETE

[Vol. 39: 989, 2012]

4/20/2012 1:33 PM

Scholastic Steroids
PEPPERDINE LAW REVIEW

begin with a technical overview of the four main cognitive enhancers. It
will then contrast their FDA-approved applications with their increasingly
off-label, brain-boosting exploitation.
A. Brain Therapy: The FDA-Approved Uses of Cognitive Enhancers
Many medications prescribed to treat neurological conditions also boost
the cognitive performances of healthy individuals because of these drugs’
distinctive effects on the human biological system.34 The most popular
cognitive enhancers are Adderall, Ritalin, Provigil, and beta blockers35
because of their individual chemical functions.
1. Adderall and Ritalin
Adderall and Ritalin are psychostimulant medications used in the
treatment of AD/HD.36 Physicians prescribe both for children,37 but only
Adderall is FDA-approved for the treatment of adult AD/HD.38 These
medications work to lessen associated behavioral problems, such as

34. Greely et al., supra note 9, at 702.
35. See infra notes 73–74 and accompanying text.
36. Nick Szuflita, Ritalin Abuse is Increasing, JOHNS HOPKINS NEWSL. (Nov. 22, 2002),
http://www.jhunewsletter.com/sports/ritalin-abuse-is-increasing-1.1144049#.T0l1Y_HOW5I.
AD/HD is the accepted acronym for two behavioral disorders—Attention Deficit Disorder (ADD)
and Attention Deficit Hyperactivity Disorder (AD/HD). Id. These neurodevelopment disorders, or
“processing deficit[s],” are lifelong and result from the underdevelopment of the area in the brain
that stops inappropriate behavior and regulates attention. Praveen Madhiraju, R.I.P. Ritalin in
Proportion! The Eighth Circuit’s Restriction on a Parent’s Right to Have Schools Accommodate the
Needs of Their Disabled Children: Debord and Davis, 95 NW. U. L. REV. 1661, 1664–65 (2001)
(explaining that children with AD/HD cannot control themselves and often disrupt class).
37. What We Know: Managing Medication for Children and Teenagers with AD/HD, NAT’L
RES. CTR. ON AD/HD, 2, http://www.help4adhd.org/documents/WWK3s.pdf [hereinafter Managing
Medication]. While physicians usually first diagnose AD/HD during childhood, it commonly lasts
into adulthood.
ADHD: Fact Sheet, CTRS. FOR DISEASE CONTROL & PREVENTION,
http://www.cdc.gov/ncbddd/actearly/pdf/parents_pdfs/ADHDFactSheet.pdf; see also Lawrence
Scahill et al., Methylphenidate: Mechanism of Action and Clinical Update, 17 J. CHILD &
ADOLESCENT PSYCHOL. NURSING 85, 85 (2004) (stating that in 60% to 80% of cases, AD/HD
persists into adolescence, and in 30% to 40% of cases, it persists into adulthood).
38. See Ritalin for Adults: An Overview, EMEDTV, http://adhd.emedtv.com/ritalin/ritalin-foradults.html (last visited Feb. 25, 2012). Nonetheless, doctors still prescribe Ritalin to adults for offlabel purposes. Id. (explaining that off-label use occurs when a medication is taken to treat a disease
or age group the FDA has not approved to use that drug). Actually, Ritalin is the most common
medication used in the treatment of AD/HD. Christina Pancheri & Mary Anne Prater, What
Teachers and Parents Should Know About Ritalin, TEACHING EXCEPTIONAL CHILD., Mar.–Apr.
1999, at 20; see also Szuflita, supra note 36 (“[O]ver 7 million children consume over eight tons of
Ritalin every year in the United States . . . .”).
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inattention, hyperactivity, and impulsivity.39 On a chemical level, they
stimulate the frontal parts of the brain by increasing and balancing the levels
of two neurotransmitters—dopamine40 and norepinephrine.41 While this
brain stimulation helps individuals with AD/HD behave normally, it allows
individuals without AD/HD to focus and concentrate better than normal.42
Adderall is available in two commercial versions—standard Adderall43
and Adderall XR.44 Both of these medications are mixtures of lRitalin, or methylphenidate
amphetamine and d-amphetamine.45
39. See ADHD: Fact Sheet, supra note 37 (listing the symptoms of AD/HD). These medications
lessen AD/HD symptoms in 70% to 80% of the children who take the stimulants. Managing
Medication, supra note 37, at 2 (“Medications are not used to control behavior. Instead, they are
used to make the symptoms of AD/HD better.”).
40. See Managing Medication, supra note 37, at 4. The brain contains at least five different
types of dopamine receptors, but dopamine is linked primarily to the brain’s pleasure system that
motivates individuals to proactively perform certain tasks. See Karl Harrison, Dopamine,
http://www.3dchem.com/molecules.asp?ID=289 (last visited Feb. 25, 2012); see also Scahill et al.,
supra note 37, at 86 (explaining that stimulants enhance dopamine function by promoting dopamine
release and blocking reuptake). Dopamine tends to promote mood elevations and “feelings of
alertness, well-being and superiority.” Szuflita, supra note 36.
41. Karl Harrison, Norepinephrine, http://www.3dchem.com/molecules.asp?ID=288 (last visited
Feb. 25, 2012). Norepinephrine is a stress hormone that affects the part of the brain that controls
attention and responding actions. Id. Although stimulants are the most common medications for
AD/HD treatment, their “mechanism of action is not completely understood.” Scahill et al., supra
note 37, at 85. Studies show that the hyperactivity and impulsivity of AD/HD is primarily associated
with the reduced effectiveness of dopamine functions in the brain, while inattention is connected with
the reduced effectiveness of norepinephrine, a neurotransmitter in the nervous system. Terje Sagvolden
& Tong Xu, L-Amphetamine Improves Poor Sustained Attention While D-Amphetamine Reduces
Overactivity and Impulsiveness as Well as Attention-Deficit/Hyperactivity Disorder (ADHD), BEHAV.
& BRAIN FUNCTIONS 10 (Jan. 23, 2008), available at http://www.behavioralandbrainfunctions.com/
content/pdf/1744-9081-4-3.pdf; see also Harrison, supra.
42. See James Pavisian, The Case for Human Ingenuity: How Adderall Has Sullied the Game,
48 WASHBURN L.J. 175, 179–80 (2008); see also Craig S. Lerner, “Accomodations” for the
Learning Disabled: A Level Playing Field or Affirmative Action for Elites?, 57 VAND. L. REV. 1043,
1069 (2004) (explaining that dopamine imbalances in the brain will increase an individual’s energy
and concentration).
43. Pavisian, supra note 42, at 177–78. Standard Adderall is an immediate-acting tablet that
lasts for four to six hours. Managing Medication, supra note 37, at 5.
44. Pavisian, supra note 42, at 177–78. Half of every Adderall tablet consists of amphetamine.
Ann P. Fenton & John M. Wunderlich, Mental Doping: The Untold Story of Modern Law School
Exams, STUDENT LAW., Jan. 2010, at 17. Adderall XR, as the longer-lasting version, is “chemically
designed ‘to give a double-pulsed delivery of amphetamines, which prolongs the release of
amphetamine . . . compared to the conventional (immediate-release) tablet formulation.’ By
allowing you to stay high longer, a single dose of Adderall is almost like two for the price of one.”
Id. at 17–18.
45. Pavisian, supra note 42, at 178 n.17 (“When amphetamines are synthesized it creates two
molecules known as d-amphetamine and l-amphetamine.”). Because of this mixture, Adderall is
called mixed-salts amphetamine or dl-amphetamine. John E. Owen, Jr., The Influence of Dl-, D-,
and L-Amphetamine and D-Methamphetamine on a Fixed-Ratio Schedule, 3 J. EXPERIMENTAL
ANALYSIS BEHAV. 293, 294 (1960). D-amphetamine is 1.5 to two times more potent than dlamphetamine and three to four times more potent than l-amphetamine. Id. D-amphetamine and lamphetamine also are different in how they affect the release of dopamine and norepinephrine. See
Sagvolden & Xu, supra note 41. Studies show that d-amphetamine—which increases wakefulness,
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hydrochloride, comes in three commercial versions—standard Ritalin,
Ritalin LA, and Ritalin SR.46 Ritalin LA and Adderall XR are longer-lasting
medications, available as extended release capsules.47
The United States Food and Drug Administration (FDA) has approved
Adderall solely for use as an AD/HD medication and Ritalin both as an
AD/HD medication and in the treatment of adult narcolepsy.48 These
stimulant medications are federally controlled substances because they can
engender abuse or lead to dependence.49 For example, Ritalin abuse creates
almost the same adverse effects as those caused by cocaine use.50
energy, and self-confidence, and decreases fatigue and appetite—is twice as potent as l-amphetamine
in reducing hyperactivity and impulsivity. Id. at 7; Karl Harrison, Dextroamphetamine,
3DCHEM.COM, http://www.3dchem.com/molecules.asp?ID=401 (last visited Feb. 25, 2012).
However, both amphetamines improve sustained attention. Sagvolden & Xu, supra note 41.
46. Managing Medication, supra note 37, at 4. Standard Ritalin is an immediate release tablet
that lasts three to four hours, while Ritalin SR is a sustained release tablet that works for six to eight
hours. Id. at 7–8.
47. Id. at 4–5 (explaining that Ritalin LA works for eight to ten hours and Adderall XR lasts for
eight to twelve hours).
48. U.S. FOOD & DRUG ADMIN., MEDICATION GUIDE: ADDERALL XR (2011) [hereinafter
MEDICATION GUIDE: ADDERALL XR], available at http://www.fda.gov/downloads/Drugs/
DrugSafety/ucm085819.pdf; U.S. FOOD & DRUG ADMIN., MEDICATION GUIDE: RITALIN (2010)
[hereinafter MEDICATION GUIDE: RITALIN], available at http://www.fda.gov/downloads/Drugs/
DrugSafety/ucm089090.pdf; see also supra notes 37–38 and accompanying text (explaining that
Adderall and Ritalin are both FDA-approved for adolescent AD/HD, but only Adderall is approved
for adult AD/HD).
49. MEDICATION GUIDE: ADDERALL XR, supra note 48, at 1; MEDICATION GUIDE: RITALIN,
supra note 48, at 1; see also Prescription Drug Abuse: Hearing Before the Subcomm. on Crim. Just.,
Drug Pol’y, & Hum. Res. Comm. on Gov’t Reform, 109th Cong. (2006) [hereinafter Prescription
Drug Abuse: Hearing], available at http://www.hhs.gov/asl/testify/t060726a.html (statement of Nora
D. Volkow, Director, Nat’l Inst. on Drug Abuse) (“[T]hese classes of psychotherapeutic drugs have
a real potential for leading to addiction, especially if abused repeatedly, at high doses, and/or by
susceptible individuals.”). Federal law classifies drugs that are popular for recreational or addictive
use into “schedules” and “imposes special handling and paperwork requirements for their use.”
Henry T. Greely, Disabilities, Enhancements, and the Meanings of Sports, 15 STAN. L. & POL’Y
REV. 99, 115 (2004). The U.S. Drug Enforcement Administration (DEA) has categorized Adderall
and Ritalin as Schedule II drugs based on their potential for abuse. U.S. DRUG ENFORCEMENT
ADMIN., DRUGS OF ABUSE: 2011 EDITION: A DEA RESOURCE GUIDE 18–19 (2011) [hereinafter
DRUGS OF ABUSE], available at http://www.justice.gov/dea/pubs/drugs_of_abuse.pdf (listing
Schedules I–V, with I encompassing drugs with the highest addictive qualities). Abuse of Schedule
II drugs may cause severe psychological or physical dependence. Id. at 9. Other Schedule II drugs
include morphine, methadone, and cocaine. Id.
50. Madhiraju, supra note 36, at 1667. Ritalin abuse causes increased heart and respiratory
rates, dilated pupils, elevated blood pressure, dry mouth, perspiration, and feelings of superiority.
Chiumino, supra note 12, at 386; see also Szuflita, supra note 36 (noting that Ritalin and cocaine
also generate aggression, hostility, and strange behavior in severe cases). Ritalin and cocaine both
block the reuptake of dopamine and actually compete for binding sites in the brain regions
responsible for reward and pleasure-related behaviors. Szuflita, supra note 36; see also supra note
40 and accompanying text. A person who injects either drug intravenously will experience a rush or
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2. Provigil
The second type of cognitive enhancer is Provigil, a psychostimulant
medication that is FDA-approved to improve wakefulness in adults
diagnosed with narcolepsy,51 obstructive sleep apnea,52 or shift-work sleep
disorder.53,54 Provigil keeps individuals awake and alert regardless of the
underlying causes for their sleepiness.55 On a chemical level, recent studies
conclude that Provigil works in a similar fashion as Adderall and Ritalin by
increasing dopamine and blocking dopamine transporters.56 Provigil also is

high because the drugs will cause a rapid and large increase in dopamine. Prescription Drug Abuse:
Hearing, supra note 49; see also CYNTHIA KUHN ET AL., BUZZED: THE STRAIGHT FACTS ABOUT
THE MOST USED AND ABUSED DRUGS FROM ALCOHOL TO ECSTASY 230 (3d ed. 2008) (warning that
the injection of Ritalin is extremely dangerous because components of the pills can lodge in the tiny
blood vessels of the lungs or eyes and create severe damage). The oral administration of Ritalin
does not produce this same rush since it elicits a gradual and sustained increase in dopamine.
Prescription Drug Abuse: Hearing, supra note 49. For this reason, abusers sometimes snort or inject
Ritalin by crushing Ritalin tablets into a fine powder or dissolving the tablets into liquid. Chiumino,
supra note 12, at 388 (comparing such methods to cocaine and heroin administration).
51. Narcolepsy is a sleep disorder characterized by a “sudden uncontrollable disposition to sleep
occurring at irregular intervals . . . .” STEDMAN’S MEDICAL DICTIONARY 923 (23d ed. 1976).
52. Obstructive sleep apnea is a breathing disorder defined by recurring interruptions of
breathing during sleep. See id. at 99.
53. Shift-work sleep disorder is a constant or recurrent pattern of sleep interruption commonly
found in people who work nontraditional hours or frequently alternate shifts. Michael J. Thorpy,
Managing the Patient with Shift-Work Disorder, 59 SUPP. J. FAM. PRAC. 824, 826 (2010) (observing
that the most common symptoms of shift-work disorder are insomnia and excessive sleepiness).
54. See Media Fact Sheet: Provigil (Modafinil) Tablets, CEPHALON, 1–2, available at
http://www.cephalon.com/fileadmin/media/downloads/PROVIGIL_Fact_Sheet.pdf
[hereinafter
Media Fact Sheet: Provigil]; Medication Guide: Provigil, U.S. FOOD & DRUG ADMIN., MEDICATION
GUIDE: PROVIGIL 35–36 (2010), available at http://www.fda.gov/downloads/Drugs/DrugSafety/
UCM231722.pdf [hereinafter MEDICATION GUIDE: PROVIGIL] (noting that Provigil does not cure
sleep disorders but works to prevent sleepiness caused by sleep disorders). Provigil is available in
100-milligram or 200-milligram doses with the general recommended dosage set at 200 milligrams
consumed once per day. Provigil, RXLIST: THE INTERNET DRUG INDEX, www.rxlist.com/provigildrug.htm (last visited Feb. 25, 2012) (advising that patients with narcolepsy take a single dose in the
morning and patients with shift- work sleep disorder take a single dose one hour before their work
shifts begin).
55. John E. Osborn, Can I Tell You the Truth? A Comparative Perspective on Regulating OffLabel Scientific and Medical Information, 10 YALE J. HEALTH POL’Y L. & ETHICS 299, 334 (2010).
In 2004, the FDA specifically rejected manufacturers’ efforts to have Provigil approved for
excessive sleepiness from any cause. Anahad O’Connor, Wakefulness Finds a Powerful Ally, N.Y.
TIMES (June 29, 2004), http://www.nytimes.com/2004/06/29/health/wakefulness-finds-a-powerfulally.html?pagewanted=all&src=pm. However, physicians still prescribe it for off-label uses, such as
aiding recovery from jet lag or staving off general fatigue. Cognitive Enhancement, All on the Mind,
supra note 3, at 103.
56. See, e.g., Monica L. Andersen et al., Dopamine Transporter-Related Effects of Modafinil in
Rhesus Monkeys, 210 PSYCHOPHARMACOLOGY 439, 440 (2010); Nora D. Volkow et al., Effects of
Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain: Clinical
Implications, 301 J. AM. MED. ASS’N 1148, 1152 (2009); see also supra notes 40–41 and
accompanying text (discussing Adderall and Ritalin’s effects on dopamine). Provigil may also
elevate norepinephrine in select brain regions by preventing its reuptake. Bertha K. Madras et al.,
Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the
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a federally controlled substance because it can prompt abuse or lead to
dependence.57
3. Beta Blockers
The final common cognitive enhancers are beta blockers, or betaadrenergic blocking agents, that are FDA-approved to manage a variety of
conditions, such as cardiac arrhythmia, diabetes, and hypertension.58
Chemically, they work by preventing two neurotransmitters—
norepinephrine (noradrenaline) and epinephrine (adrenaline)—from binding
to beta receptors, which, in turn, blocks the effects of adrenaline.59
Transporters and Trace Amine Activity in Vitro, 319 J. PHARMACOLOGY & EXPERIMENTAL
THERAPEUTICS 561, 567 (2006); see also Dov Fox, Safety, Efficacy, and Authenticity: The Gap
Between Ethics and Law in FDA Decisionmaking, 2005 MICH. ST. L. REV. 1135, 1142. However,
Provigil’s precise mechanism of action is not fully understood, although it is known to affect the part
of the brain that regulates wakefulness. Osborn, supra note 55, at 334.
57. MEDICATION GUIDE: PROVIGIL, supra note 54, at 36; Media Fact Sheet: Provigil, supra note
54. The DEA has categorized Provigil as a Schedule IV drug. DRUGS OF ABUSE, supra note 49, at
9. Relative to substances listed on Schedules I–III, Provigil has a low potential for abuse and may
lead to limited physical or psychological dependence. See id.; see also supra note 49 and
accompanying text (explaining that Adderall and Ritalin are Schedule II drugs with higher potentials
for addiction). Other Schedule IV drugs include Xanax, Paxor, and Valium. DRUGS OF ABUSE,
supra note 49, at 23. Although Provigil is listed as a low-abuse substance, its potential for abuse is
still surrounded by debate. See, e.g., Andersen et al., supra note 56, at 440; Volkow et al., supra
note 56, at 1148. Similar to Ritalin, Provigil binds to the same dopamine transporter sites as
cocaine. Volkow et al., supra note 56, at 1152; see also supra note 50 and accompanying text. Still,
reports of Provigil abuse are rare and significantly less frequent than those for Adderall and Ritalin.
Volkow et al., supra note 56, at 1153 (suggesting, however, that the “risk for addiction in vulnerable
persons merits heightened awareness”).
58. Beta Blockers: Drug Information, RXLIST: THE INTERNET DRUG INDEX, www.rxlist.com/
script/main/art.asp?articlekey=90349 (last visited Feb. 25, 2012) (listing FDA-approved and offlabel uses). Since the FDA-approved beta blockers in the 1960s, they have been the most commonly
prescribed medication for heart failure and hypertension. Vabren L. Watts, Beta-Blockers Used by
Musicians, Athletes, Students to Enhance Performance, PHILA. INQUIRER (Aug. 16, 2010),
http://articles.philly.com/2010-08-16/news/24973169_1_beta-blockers-graduatestudent-performance
-anxiety. Traditionally, beta blockers were used in the treatment of heart problems because they
“reduce blood pressure and improve the heart’s ability to relax and pump blood more effectively
over time.” Shayna M. Sigman, Are We All Dopes? A Behavioral Law & Economics Approach to
Legal Regulation of Doping in Sports, 19 MARQ. SPORTS L. REV. 125, 156 (2008).
59. Beta Blockers: Drug Information, supra note 58; see also Carl Elliott, In Defense of the Beta
Blocker: Is This a Performance Drug That Could Actually Increase the Fairness of Olympic
Contests?, ATLANTIC (Aug. 20, 2008), http://www.theatlantic.com/magazine/archive/2008/08/indefense-of-the-beta-blocker/6961 (explaining that beta blockers block particular nervous system
receptors). These nervous system or beta receptors are classified into two types—beta-1 receptors
that control the heart and beta-2 receptors that control smooth muscle function in the body. See E.
Davis et al., The Rush to Adrenaline: Drugs in Sport Acting on the β-Adrenergic System, 154 BRIT.
J. PHARMACOLOGY 584, 584–85 (2008). “These receptors also happen to be the ones that get
activated in times of fear or anxiety . . . .” Elliott, supra. However, beta blockers do not alleviate
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Essentially, this medication prevents the body from triggering its “fight or
flight” response.60
More than fifteen different brands of beta blockers are available in the
United States;61 some affect the heart, while others influence both the heart
and blood vessels.62 Two of the most common beta blockers are propranolol
(brand name Inderal)63 and metoprolol (brand names Lopressor and ToprolXL).64 Lopressor is the immediate release version of metoprolol,65 while
Toprol-XL is the extended-release tablet.66 Unlike the other cognitive
enhancers, beta blockers are generally not addictive.67
Cognitive enhancers vary in their methods of administration and
addiction potentials mainly because they differ in how they scientifically
affect the human body.68 Nonetheless, the FDA has approved all of them for

anxiety; instead, they block the outward signs of anxiety. Id. Unlike other cognitive enhancers, beta
blockers do not affect dopamine levels. See supra notes 40, 56 and accompanying text.
60. Sigman, supra note 58, at 156 (describing beta blockers as inducing a calming effect). Such
an effect has generated off-label beta blocker use in the public performance setting. Michael H.
Shapiro, The Technology of Perfection: Performance Enhancement and the Control of Attributes, 65
S. CAL. L. REV. 11, 42 (1991) (acknowledging beta blocker use by musicians, athletes, and other
performers).
61. Beta Blockers: Drug Information, supra note 58.
62. Davis et al., supra note 59, at 584 (explaining that the effects of beta blockers depend on the
type of beta receptor they block); see also supra note 59 and accompanying text.
63. See Beta Blockers: Drug Information, supra note 58. Inderal was the first beta blocker with
widespread use and works on both the heart and blood vessels. Adhi Sharma et al., Beta-Blocker
Toxicity, MEDSCAPE REFERENCE, http://emedicine.medscape.com/article/813342-print (last updated
Oct. 27, 2011). It is a nonselective beta blocker because it blocks both types of beta receptors. Id.;
see also supra note 59 and accompanying text. Inderal is available in tablets ranging from ten to
eighty milligram doses with a recommended dosage generally beginning at forty milligrams twice
daily. Inderal, RXLIST: THE INTERNET DRUG INDEX, www.rxlist.com/inderal (last visited Feb. 25,
2012); see also Mark A. Dotson, Restatement Third and Prescription Drug Liability: A Tough Pill to
Swallow or Business as Usual?, 4 T.M. COOLEY J. PRAC. & CLINICAL L. 29, 36–37 (2000) (noting
that Inderal is also available in “injectable form”). Daily doses above 160 milligrams may cause
fatigue, lethargy, and vivid dreams. U.S. FOOD & DRUG ADMIN., MEDICATION GUIDE: INDERIDE 9
(2008), available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/ 018031s035lbl.pdf.
64. See Beta Blockers: Drug Information, supra note 58. See generally Metoprolol, PUBMED
HEALTH, http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000795 (last visited Feb. 25, 2012).
Unlike Inderal, Toprol-XL is a selective beta blocker because it blocks only the beta-1 receptor.
Beta Blockers: Drug Information, supra note 58; see also supra notes 59, 63 and accompanying text.
65. See U.S. FOOD & DRUG ADMIN., MEDICATION GUIDE: LOPRESSOR HCT 1 (2008), available
at http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018303s033lbl.pdf.
Lopressor’s
initial dosage is usually 100 milligrams daily, but its most effective dose is between 100 to 450
milligrams. Id. at 9.
66. See U.S. FOOD & DRUG ADMIN., MEDICATION GUIDE: TOPROL-XL 1 (2009), available at
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019962s038lbl.pdf.
Toprol-XL is
available in tablets ranging from 25 to 200 milligram doses. Id. at 1, 15.
67. Watts, supra note 58. Unlike Adderall, Ritalin, and Provigil, the DEA has not categorized
beta blockers as controlled substances. See DRUGS OF ABUSE, supra note 49, at 15–25; see also
supra notes 49, 57 and accompanying text.
68. See, e.g., supra notes 41, 54, 59, 67 and accompanying text.
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particular purposes while still explicitly declining to include cognitiveenhancement use.69
B. Brain Gain: The Off-Label Benefits of Cognitive Enhancers
Medicinal off-label use is the utilization of a drug for purposes that are
not FDA-approved.70 In the last decade, physicians have increasingly
prescribed medications for off-label cognitive-enhancement reasons in a
growing trend termed “cosmetic neurology”—where the focus is
enhancement rather than treatment.71 As pharmaceutical laboratories race to
develop the next blockbuster smart drug, commentators agree that the new
frontier is mental doping.72 Although extensively prescribed for such an offlabel function,73 Adderall, Ritalin, Provigil, and beta blockers are just the

69. See supra notes 48, 54, 58 and accompanying text (listing the FDA-approved uses for each
cognitive enhancer).
70. Letter from Jennifer C. Jaff, Exec. Director, Advocacy for Patients with Chronic Illness,
Inc., to Internal Revenue Serv. (Sept. 15, 2010), available at 2010 WL 3829485 (“To give a simple
example, if the approved use of aspirin were to address pain, the use of aspirin to prevent heart
attacks would be considered off-label.”). Similarly, off-label marketing occurs when drug
manufacturers promote their products to users or in dosages not approved by the FDA. Fox, supra
note 56, at 1165–70 (listing arguments for and against FDA regulation of off-label use and
prescription). One doctor at Harvard University asserts that growing consumer demand for off-label
use “reflects our bombardment with advertisements imploring us to ‘ask your doctor if this pill is
right for you.’” Richard Kadison, Getting an Edge—Use of Stimulants and Antidepressants in
College, 353 NEW ENG. J. MED. 1089, 1089 (2005).
71. V. Cakic, Smart Drugs for Cognitive Enhancement: Ethical and Pragmatic Considerations
in the Era of Cosmetic Neurology, 35 J. MED. ETHICS 611, 611 (2009) (warning that the student
demographic could be the largest non-therapeutic market for future smart drugs). One influential
approach to the ethics of enhancement has been to define the term “enhancement” as any
intervention designed to improve human functioning beyond what is necessary to restore or sustain
good health—in other words, it is always more than mere treatment. Julian Savulescu, Justice,
Fairness, and Enhancement, 1093 ANNALS N.Y. ACAD. SCI. 321, 322 (2006).
72. See Cognitive Enhancement, All on the Mind, supra note 3, at 103 (arguing that mind
expansion may soon become big business); Karen Kaplan & Denise Gellene, They’re Bulking Up
Mentally, L.A. TIMES (Dec. 20, 2007), http://articles.latimes.com/2007/dec/20/science/scibraindoping20 (“Whatever company comes out with the first memory pill is going to put Viagra to
shame.”). One researcher at Cambridge University estimates that scientists are currently working on
more than 600 new cognition enhancers. Cognitive Enhancement, All on the Mind, supra note 3, at
103.
73. Kaplan & Gellene, supra note 72 (noting that some students, academics, musicians,
corporate executives, and professional poker players currently take these drugs to clarify minds,
control emotions, and improve concentration); see also Cognitive Enhancement, All on the Mind,
supra note 3, at 103 (describing off-label use as a means to increase energy and boost exam
performance).

1001

DO NOT DELETE

4/20/2012 1:33 PM

precursors to this anticipated smart drug, which could make mind
enhancement “as ordinary as a cup of coffee.”74
Adderall and Ritalin75 work chemically by increasing two
neurotransmitters—dopamine and norepinephrine—within the brain.76 In a
healthy person, this brain stimulation enhances energy and concentration.77
Recent tests have affirmed these positive cognitive effects.78 Such a perk
understandably has popularized stimulant medications on United States
college campuses.79 For example, one study, which surveyed 10,904
students at 119 four-year universities, found that 6.9% of these students had
taken prescription stimulants for non-medical uses.80 Other surveys have
yielded higher numbers ranging from 16% to 60%.81 While some of these
74. Melissa Healy, Sharper Minds, L.A. TIMES (Dec. 20, 2004), http://articles.latimes.com/
2004/dec/20/health/he-smartdrugs20. “In the coming years science is likely to create more novel
drugs that boost memory, concentration and planning. These may well be less harmful than
coffee—and will almost certainly be more useful.” Smart Drugs: Drugs to Make You Cleverer Are
in the Test-Tube, ECONOMIST (May 24, 2008), http://www.economist.com/ node/11412603.
75. See supra note 36 and accompanying text.
76. See supra notes 40–41 and accompanying text.
77. See supra note 42 and accompanying text. For example, one California writer confessed to a
journalist that he managed to speed write several lucrative soft porn novels while on Ritalin.
Minette Marrin, It’s a No-Brainer: Bring on the Pills That Will Make Us Smarter, SUNDAY TIMES,
Jan. 3, 2010, at 14.
78. See, e.g., C. Thomas Gualtieri & Lynda G. Johnson, Medications Do Not Necessarily
Normalize Cognition in ADHD Patients, 11 J. ATTENTION DISORDERS 459, 460, 464 (2008) (noting
that stimulant use improved school performance); Maia Szalavitz, Popping Smart Pills: The Case for
Cognitive Enhancement, TIME (Jan. 6, 2009), http://www.time.com/time/health/article/
0,8599,1869435,00.html (“Research shows that in normal people, stimulants consistently and
significantly improve learning of material that must be recalled days later—exactly what you want
from a drug when you are prepping for exams.”).
79. Alan D. DeSantis & Audrey Curtis Hane, “Adderall Is Definitely Not a Drug:”
Justifications for the Illegal Use of ADHD Stimulants, 45 SUBSTANCE USE & MISUSE 31, 31 (2010)
(listing seven scientific surveys conducted at different college campuses). “[S]ome of the most
competitive college campuses are rife with illicit use of ADD medication.” Chris Good, Give
Scientists Performance-Enhancing Drugs, ATLANTIC (June 30, 2010), http://www.theatlantic.com/
special-report/ideas/archive/2010/06/give-scientists-performance-enhancing-drugs/58941.
80. Sean Esteban McCabe et al., Non-Medical Use of Prescription Stimulants Among U.S.
College Students: Prevalence and Correlates from a National Survey, 99 ADDICTION 96, 102–03
(2005) (finding that cognitive-enhancement drug use is highest among students from colleges with
more competitive admission standards).
81. See, e.g., Alan D. DeSantis et al., Illicit Use of Prescription ADHD Medications on a
College Campus: A Multimethodological Approach, 57 J. AM. C. HEALTH 315, 316 (2008)
(reporting that 34% of the surveyed students claimed to have used AD/HD drugs illegally); Christian
J. Teter et al., Illicit Use of Specific Prescription Stimulants Among College Students: Prevalence,
Motives, and Routes of Administration, 26 PHARMACOTHERAPY 1501, 1507 (2006) (explaining that
the most common motives for illegal stimulant use among the surveyed students were improved
concentration and aid in studying). One study at the University of Wisconsin found that a staggering
one in five students had taken either Ritalin or Adderall illegally. Szuflita, supra note 36. Another
survey estimated that 7% to 25% of all college students had used Adderall “not to get high, but to
get higher grades.” Fenton & Wunderlich, supra note 44, at 18 (emphasis added); see also Rob
Goodman, Cognitive Enhancement, Cheating, and Accomplishment, 20 KENNEDY INST. ETHICS J.
145, 148 (2010) (noting that the U.S. Department of Education identifies Ritalin as the most
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students buy the drugs illegally on the black market, others simply use their
legal prescriptions in non-FDA-approved ways.82 Academically, some
students who take these stimulants significantly improve their focus and
concentration to the point where they morph into study machines.83 Now
this coveted power has placed bottles of Adderall and Ritalin in the medicine
cabinets of higher education—where medical84 and law85 school students
face steep grading curves and declining job prospects.

commonly abused study drug on college campuses). More recently, 60 Minutes reported that 50% to
60% of all college students had used AD/HD medications. 60 Minutes: Popping Pills a Popular
Way to Boost Brain Power (CBS television broadcast Apr. 25, 2010) [hereinafter 60 Minutes],
available at http://www.cbsnews.com/2100-18560_162-6422159.html.
82. See Fenton & Wunderlich, supra note 44, at 17; see also 60 Minutes, supra note 81 (noting
that black market stimulant pills cost between three and five dollars on college campuses).
Interestingly, prescriptions for stimulant medications have doubled in the last eight years from four
million to eight million; during that same time span, calls to poison-control centers reporting
overdoses of legal stimulants by young adults shot up seventy-six percent. Walter Kirn, A
Pharmacological Education, N.Y. TIMES (Sept. 2, 2009), http://www.nytimes.com/2009/09/06/
magazine/06FOB-wwln-t.html.
83. Pavisian, supra note 42, at 181, 184 (emphasizing that stimulants clear minds and improve
concentration for the tasks at hand); see, e.g., Margaret Talbot, Brain Gain: The Underground World
of “Neuroenhancing” Drugs, NEW YORKER (Apr. 27, 2009), http://www.newyorker.com/reporting/
2009/04/27/090427fa_fact_talbot (featuring a Harvard student who experimented with Adderall
dosage to make his impossible schedule of work, school, and recreation “possible”). One consumer
described Adderall as a career transformer: “I’m talking about being able to take on twice the
responsibility, work twice as fast, write more effectively, manage better, be more attentive, devise
better and more creative strategies.” Carey, supra note 1.
84. Jadon R. Webb et al., Contemplating Cognitive Enhancement in Medical Students and
Residents, 53 PERSP. BIOLOGY & MED. 200, 200 (2010) (exploring stimulant use among medical
students for increased study, higher grades, and better care of patients). In recent years, the growing
number of medical students who take Adderall and Ritalin has created a “significant controversy”
that the health community has just begun to acknowledge. Alison Hayward et al., Stimulant Use
Among Professional Students, STUDENT DOCTOR NETWORK (June 28, 2008),
http://studentdoctor.net/2008/06/stimulant-use-among-professional-students; see also Katharine
Hibbert, Ways to Make You Think Better, GUARDIAN (Nov. 8, 2007), http://www.guardian.co.uk/
society/2007/nov/08/health.lifeandhealth (describing Ritalin use by medical students as
“unexceptional”). One medical student said it was impossible to juggle both academics and a social
life without stimulant use—“The only people who get through the (med school) program I’m in
either use stimulants or have no social life whatsoever. There is no other way.” An Ethical Look at
Cognitive Stimulants, Part 1, TECHNOLOGICAL CITIZEN, http://thetechnologicalcitizen.com/?p=2444
(last visited Feb. 27, 2012). However, another student from the same medical school chat forum
countered, “People use these medications because they’re lazy, and because they have no study
habits. They’re a crutch for people who need a last minute way to get work done, fast.” Id.
85. See Fenton & Wunderlich, supra note 44, at 17 (commenting on the extensive use of
stimulant medications by law school students). One commentator explained this prevalence aptly:
They’re well aware of the dire economic news—big law firms instituting hiring freezes;
whole industries . . . imploding—and it’s natural that they would welcome any advantage
in their quests to get the grades that will get them the jobs that will get them the insurance
that will get them the medications to do the jobs.
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Another medication increasingly booking its appearances during final
exams is Provigil,86 a pill that boosts dopamine levels and blocks dopamine
transporters within the brain—keeping individuals awake and alert.87
Provigil, short for “promotes vigilance,”88 is a “nap in the form of a pill”89
that leaves its users refreshed and alert despite hours or even days of
wakefulness.90 Individuals take this drug for off-label uses like jet-lag
recovery and exam-performance enhancement.91 In fact, more than eighty

Kirn, supra note 82. In 2008, the Volokh Conspiracy group blog, composed mostly of law
professors, posted a poll that asked law school students: “[H]ow common is use of Adderall and/or
Ritalin among law students who do not have a prescription to . . . boost law school performance?”
Law Student Use of Adderall and/or Ritalin, VOLOKH CONSPIRACY (Mar. 26, 2008, 2:10 PM),
http://volokh.com/posts/1206555052.shtml. Of 1063 responses, only 157 stated that such stimulant
use was rare or never happened; 350 voted that fifty percent or more of all law school students had
used Adderall or Ritalin to improve grades. Id. In 2010, The Onion chipped in with its own satirical
commentary in an article that reported Harvard University’s conferment of an honorary doctorate
degree on a bottle of Adderall for its cognitive “inspiration to [them] all.” Adderall Receives
Honorary Degree from Harvard, ONION (May 31, 2010), http://www.theonion.com/articles/adderallreceives-honorary-degree-from-harvard,17527.
86. See supra note 54 and accompanying text.
87. See supra notes 55–56 and accompanying text; see also Miriam Hill, Concerns Raised on
Cephalon’s Stay-Awake Drug Provigil, PHILA. INQUIRER, Mar. 17, 2009, at C01 (noting the
increasing evidence that shows Provigil use by students and professors as a brain-boosting drug).
One psychologist, who works at Cambridge University and writes about the ethics of cognitive
enhancement, stated that her first Provigil session allowed her to intensely “work at her computer for
hours straight.” Kaplan & Gellene, supra note 72. One study demonstrated that test subjects who
took Provigil were able to concentrate on a specific task “for as long as fifty-four consecutive
hours.” Greely, supra note 49, at 127.
88. Andrew Pollack, A Biotech Outcast Awakens, N.Y. TIMES (Oct. 20, 2002),
http://www.nytimes.com/2002/10/20/business/a-biotech-outcast-awakens.html?pagewanted=all&src
=pm.
89. O’Connor, supra note 55. Provigil has “rapidly become a tempting pick-me-up to a nation
that battles sleep with more than 100 million cups of coffee a day.” Id.
90. Sanneke A.M. van Vliet et al., Efficacy of Caffeine and Modafinil in Counteracting Sleep
Deprivation in the Marmoset Monkey, 197 PSYCHOPHARMACOLOGY 59, 60 (2007) (listing studies
that demonstrate Provigil’s beneficial effects during sleep deprivation). See generally Joseph V.
Baranski et al., Effects of Modafinil on Cognitive Performance During 40 Hr of Sleep Deprivation in
a Warm Environment, 14 MIL. PSYCHOL. 23, 23 (2002); Joseph V. Baranski et al., Modafinil During
64 Hr of Sleep Deprivation: Dose-Related Effects on Fatigue, Alertness, and Cognitive
Performance, 10 MIL. PSYCHOL. 173, 173 (1998). Physicians prescribe Provigil to pilots, truck
drivers, college students, and any others who “simply were sleepy or tired during the day without
any associated medical condition.” Osborn, supra note 55, at 335 (“FDA’s Dr. Robert Temple
suggested that he was not necessarily troubled by off-label use of Provigil in the case of truck drivers
or others who might be driving while sleepy, noting that ‘[i]f they’re driving next to me, I think I’d
prefer they be on it.’”).
91. See supra note 55 and accompanying text. Provigil enhances cognitive abilities in healthy
individuals; for example, it enables people to remember an extra digit when the average person can
hold only seven random digits in his or her memory. Cognitive Enhancement, All on the Mind,
supra note 3, at 103. Besides increasing digit span, it also improves spatial planning, visual patternrecognition memory, and response inhibition. Danielle C. Turner et al., Modafinil Improves
Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia, 29
NEUROPSYCHOPHARMACOLOGY 1363, 1364 (2004).
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percent of all prescriptions for this medication are for off-label purposes.92
Commentators have described this energy drug “as a more effective, nonaddictive substitute to caffeine and amphetamines.”93 Doctors declare it the
new “lifestyle drug for a sleep-deprived 24/7 society.”94 Johann Hari, an
award-winning journalist who writes for the New York Times, Los Angeles
Times, and New Republic, described his experiments with Provigil—as he
took 200 milligrams every day for five days:
I picked up a book about quantum physics and super-string
theory I have been meaning to read for ages . . . . It had been
hanging over me, daring me to read it. Five hours later, I realised
[sic] I had hit the last page . . . . I hadn’t noticed anything, except
the words I was reading, and they came in cool, clear passages; I
didn’t stop or stumble once.
Perplexed, I got up, made a sandwich—and I was overcome with
the urge to write an article that had been kicking around my
subconscious for months. It rushed out of me in a few hours, and it
was better than usual . . . .
....

92. See O’Connor, supra note 55; see also Osborn, supra note 55, at 305 (explaining that current
law prohibits drug manufacturers from promoting off-label uses for their products). Interestingly,
Cephalon, the U.S. manufacturer of Provigil, actually facilitated off-label campaigns until 2008.
Evelyn Pringle, The Rise and Fall of Provigil—Part II, EVELYN PRINGLE’S CATALOG OF ARTICLES
(Sept. 21, 2010, 4:49 AM), http://evelynpringle.blogspot.com/2010/09/rise-and-fall-of-provigil-partii.html (noting that Provigil sales continued to increase and topped the billion dollar mark in 2009).
93. Fox, supra note 56, at 1142; see also O’Connor, supra note 55 (describing Provigil as a
small, white pill that “revs up the central nervous system without the jitteriness of caffeine or the
addiction and euphoria of amphetamines”). However, some contend that Provigil is not significantly
more effective at promoting wakefulness than a large dose of caffeine. Mehlman, supra note 13, at
484.
94. Pollack, supra note 88, at 31 (“[O]ne analyst at a brokerage firm . . . [said], ‘I used to drink
twelve cups of coffee a day and now I don’t do that anymore.’”). Not all doctors consider Provigil
beneficial; for example, Dr. Martha J. Farah, director of the Center for Cognitive Neuroscience at the
University of Pennsylvania, explained, “‘This drug enables us to be that much more workaholic and
that much more obsessed with accomplishments and productivity, and I think our society is already
extreme along those lines . . . . [N]atural checks on that tendency, like needing to go to bed, are
being rolled back by [Provigil].’” O’Connor, supra note 55. Others contend that the off-label
cognitive use of Provigil represents a high-risk behavior that calls for further monitoring and
intervention efforts. See Andersen et al., supra note 56, at 446.
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The next morning I woke up and felt immediately alert.
Normally it takes a coffee and an hour to kick-start my brain; today
I’m ready to go from the second I rise. And so it continues like this,
for five days: I inhale books and exhale articles effortlessly . . . . I
keep waiting for an exhausted crash, and it doesn’t seem to come.95
Because Provigil costs almost twenty-seven dollars per pill,96 it is
primarily popular with the higher education and income crowd.97 For
example, one recent survey of 1400 academics from sixty countries reported
that one in five had taken medications for non-medical cognitive-enhancing
purposes;98 of that one in five, 40% used Provigil.99 Students see it as the
difference between an A and a B,100 where enhanced concentration,

95. Johann Hari, My Experiment with Smart Drugs, JOHANNHARI.COM (May 5, 2008),
www.johannhari.com/2008/05/06/my-experiment-with-smart-drugs (describing how he bought
Provigil online from a foreign pharmacy and without a prescription). For a similar account detailing
a writer’s personal experiences with Provigil, see Chen, supra note 3, at 170.
96. In March 2012, one hundred 200-milligram tablets of Provigil cost $2661.20—or $26.61 per
pill—at drugstore.com. Provigil, DRUGSTORE.COM, http://www.drugstore.com/provigil/200mgtablets/qxn63459020101 (last visited Mar. 1, 2012). Dr. Eric Heiligenstein, a psychiatrist at the
University of Wisconsin, noted that while Provigil is a “very clean drug,” the “main barrier to more
widespread use is that it’s expensive, which will change as more insurance companies start to cover
it.” O’Connor, supra note 55.
97. See Kirby, supra note 7, at 94 (calling Provigil an “entrepreneur’s drug of choice”); see, e.g.,
O’Connor, supra note 55 (describing Provigil use as a “fixture” among college students, computer
programmers, and “others determined to burn the midnight oil”); 60 Minutes, supra note 81
(depicting an interview with a Harvard professor who uses Provigil and calls such cognitive
enhancement “extremely common” in his profession).
98. Brendan Maher, Poll Results: Look Who’s Doping, 452 NATURE 674, 674 (2008).
“Apparently, while the chattering classes tsk-tsked the doping habits of pro athletes, those within
their own circles—writers, designers, scientists, scholars—have been juicing up themselves, or
secretly wishing they could.” Chen, supra note 3, at 170.
99. Maher, supra note 98, at 674 (noting that half of the respondents reported adverse side
effects). One-third of the respondents purchased the drug over the Internet, while the remaining
two-thirds obtained Provigil from pharmacies or with prescriptions. Id. at 675. “‘We aren’t the teen
clubbers popping uppers to get through a hard day running a cash register after binge drinking,’
wrote a Ph.D. research scientist . . . . ‘We are responsible humans.’” Alexis Madrigal, Wired.com
Readers’ Brain-Enhancing Drug Regimens, WIRED (Apr. 24, 2008), http://www.wired.com/
medtech/drugs/news/2008/04/smart_drugs. Other individuals who used Provigil in their cognitiveenhancement drug regimens included neuroscience graduate students, lawyers, and an elementary
school teacher. Id.; see also Hill, supra note 87, at C01 (detailing the nonmedical use of Provigil
among students and professionals).
100. Studies report Provigil’s presence on both sides of the Atlantic—in the hands of U.S. and
English university students. See, e.g., Katy Lee, Wired Awake, VARSITY (Nov. 16, 2007),
http://www.varsity.co.uk/news/807; Margaret Talbot, Can a Daily Pill Really Boost Your Brain
Power?, OBSERVER (Sept. 20, 2009), http://www.guardian.co.uk/science/2009/sep/20/
neuroenhancers-us-brain-power-drugs (describing students’ personal experiences with the
medication); see also Madrigal, supra note 99 (coining this new era of scholastic drug
experimentation as “personalized research”).
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alertness, and short-term memory are useful qualities for complex term
papers and all-night study sessions.101
The final commonly utilized cognitive enhancer is the beta blocker,102
which primarily enables off-label use in the public-performance setting.103
Because beta blockers block the effects of adrenaline, they leave individuals
calm in typically anxious situations.104 Most likely, the first performers to
exploit this off-label result were musicians, whose hands tend to become
clammy and tremble during concert performances.105 Now, beta blockers
are found in a variety of other settings—golf tournaments,106 pistol shooting
contests,107 and college campuses.108 In a 1991 study investigating beta

101. Being Provigilant About Enhancing the Brain, BIOETHICS.NET BLOG (June 27, 2006, 12:59
AM), http://www.bioethics.net/2006/06/being-provigilant-about-enhancing-the-brain (describing
Provigil as a new smart pill and even a possible ticket to Harvard Law). But cf. Gary Stix,
Turbocharging the Brain, SCI. AM., Oct. 2009, at 46, 53 (“Users with lower IQs appear to derive a
large performance boost from [Provigil], whereas those with more innate ability show little or no
benefit.”). Specifically, medical students and residents admit to using Ritalin and Provigil to face
24-hour or longer work shifts, but the medical community largely polices itself, leaving many
students with the belief that cognitive enhancement will continue to spread if not checked. Greely,
supra note 6, at 1143; Mark Meier, The End of Impairment? Generation Rx Goes to Medical School,
SCI. PROGRESS (Sept. 30, 2008), http://scienceprogress.org/2008/09/the-end-of-impairment.
102. See supra note 58 and accompanying text.
103. See supra note 60 and accompanying text.
104. See supra notes 59–60 and accompanying text; see also Elliott, supra note 59 (noting that
the drug can keep the voice from quavering, hands from trembling, heart from pounding, and
forehead from sweating).
105. Elliott, supra note 59 (describing a 1970s British study that tested the effects of beta
blockers on musicians and found a significant improvement with usually nervous players); see also
Watts, supra note 58 (reporting beta blocker use among musicians and music students). Musicians
primarily rely on beta blockers to control fine motor tremors. Claudio M. Tamburrini & Torbjorn
Tannsjo, Transcending Human Limitations, 1 SPORT, ETHICS & PHIL. 113, 113 (2007). One
musician estimates that three-quarters of her peers use the drugs at least occasionally. Kaplan &
Gellene, supra note 72. While professional musicians have taken this medication for years to
combat stage fright, students in music schools are increasing their prescriptions too. David Stabler,
Better Music Through Chemistry? Music Students Turn to Medications to Calm Stage Fright,
PORTLAND OREGONIAN (Mar. 3, 2010), http://www.oregonlive.com/performance/index.ssf/
2010/03/better_music_through_chemistry.html.
106. Sigman, supra note 58, at 156–57. Several top golfers have admitted to taking beta blockers
or accused others of such use. See Christopher Clarey, Clean as a Whistle That’s Never Blown,
INT’L HERALD TRIB., July 17, 2004, at 18; Dave Feschuk, PGA Drug Tests Looming, TORONTO
STAR, Sept. 7, 2006, at B01.
107. Davis et al., supra note 59, at 586 (noting beta blocker use among athletes to reduce motor
tremors, particularly in motor racing and pistol shooting). In 2008, an Olympic pistol shooter lost
his medals after testing positive for beta blockers, and at the 2010 Paralympics, a Swedish
wheelchair curler garnered suspension after taking a beta blocker. Watts, supra note 58. In general,
beta blockers are used by individuals whose activities require “precision.” Shapiro, supra note 60, at
42. “Some may prefer to view such enhancement as more athletic than intellectual, but there is no
sharp line here.” Id.
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blocker effectiveness on test performance, thirty-two high school students,
who had already taken the SAT and exhibited general exam anxiety,
received a beta blocker one hour before retaking the test. The results? On
average, they scored 130 points higher than their previous exams.109
Professionally, both lawyers and doctors use beta blockers to combat the
fear of public speaking.110
All four of these cognitive enhancers have already claimed a place next
to textbook supplements and commercial outlines as modern educational
study aids,111 but with this rise in academic brain boosting, proponents and
critics have called for a strict ethical scrutiny in certain situations, such as
lower education classrooms.112 Medical and law schools, which are ethically
governed settings, also merit the same stringent analysis.113 As medical and
law school students continue to jump on the bandwagon of cosmetic
neurology,114 the question becomes whether their medicinal brain boosting is
actually cheating.115
108. Watts, supra note 58 (reporting that beta blockers significantly improve exam performance
for students who suffer from test anxiety). One scientific study noted that “beta-blockers may be
particularly useful for students who do not do themselves justice because of examination nerves.”
Desmond Kelly, Beta-Blockers in Anxiety, 1 STRESS MED. 143, 148 (1985). While beta blockers
still allow energizing adrenaline to flow through people’s bodies, they prevent test takers from
feeling that adrenaline, so they are not distracted by their own nervousness. Kaplan & Gellene,
supra note 72.
109. Harris C. Faigel, The Effect of Beta Blockade on Stress-Induced Cognitive Dysfunction in
Adolescents, 30 CLINICAL PEDIATRICS 441, 441 (1991) (noting that a normal score increase would
have been thirty points). Other studies have duplicated similar results with other testing situations.
See, e.g., D.Q. Beversdorf et al., Central Beta-Adrenergic Modulation of Cognitive Flexibility, 13
NEUROREPORT 2505, 2505 (2002) (using anagram problems); D.Q. Beversdorf et al., Noradrenergic
Modulation of Cognitive Flexibility in Problem Solving, 10 NEUROREPORT 2763, 2764–66 (1999)
(using three problem solving tasks—number series, shape manipulation, and anagrams); J.A. Silver
et al., Effect of Anxiolytics on Cognitive Flexibility in Problem Solving, 17 COGNITIVE & BEHAV.
NEUROLOGY 93, 93 (2004) (using three test sessions). Of course, beta blockers work best for
nervous test takers, while non-anxious students show minimal improvement. See Elliott, supra note
59 (“[T]hey seem to level the playing field for anxious and non-anxious performers, helping nervous
performers much more than they help performers who are naturally relaxed.”).
110. See Zev Chafets, Drugs that Give You an Edge Just Part of the Game, J. GAZETTE (Fort
Wayne) (Feb. 15, 2009), http://www.journalgazette.net/article/20090215/EDIT05/302159938/1/EDIT01 (“Trial lawyers and Broadway actors pop beta blockers to ward off stage fright.”).
Kaplan & Gellene, supra note 72 (“[S]ome doctors had . . . used the drugs themselves to calm their
own nerves before making presentations at medical meetings.”). In the 2008 Nature survey, 15% of
its academic respondents who reported use of cognitive-enhancement medications picked beta
blockers as their drug of choice before giving presentations. Maher, supra note 98, at 674; see also
Kelly, supra note 108, at 147–48 (“[T]here is no doubt that beta-blocking drugs can alleviate the
unpleasant subjective symptoms associated with public speaking, especially in susceptible people.
The major advantage is that the speaker is not sedated in any way, and so is not robbed of mental
agility.”).
111. See supra notes 79, 100, 108 and accompanying text.
112. See supra notes 10–12 and accompanying text.
113. See supra notes 15–25 and accompanying text.
114. See supra notes 71, 101, 108 and accompanying text.
115. See supra note 26 and accompanying text.
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III. NO BRAINER: IS COGNITIVE ENHANCEMENT CHEATING?
Taking medications—such as Adderall, Ritalin, or Provigil—without a
physician’s prescription is illegal and, as such, is “a per se ethics
violation.”116 While federal and state statutes govern the sale, distribution,
and use of prescription drugs,117 the Controlled Substances Act compiles
national regulations that individual states apply as their legal floor.118 This
Act prohibits a person from “knowingly or intentionally” distributing,
dispensing, or possessing a controlled substance not lawfully obtained from
a doctor.119 As federally classified drugs, Adderall, Ritalin, and Provigil are
such substances.120 Federal and state laws stipulate that individuals who (1)
take these cognitive-enhancement medications without prescriptions, (2) buy
these medications from others, or (3) sell and share these medications with
others are subject to criminal penalties—including arrest, fines, and
imprisonment.121 Both the AMA and ABA recognize illegal acts like these

116. Fenton & Wunderlich, supra note 44, at 17; see also infra note 122 and accompanying text.
Medical prescriptions are licenses that permit a drug’s sale or use in certain circumstances.
RICHARDS, supra note 2, at 190. States license doctors as “competent medical professional[s]” so
that they can then license the sale or use of medications. Id.
117. See Leamor Kahanov et al., Adherence to Drug-Dispensation and Drug-Administration
Laws and Guidelines in Collegiate Athletic Training Rooms: A 5-Year Review, 45 J. ATHLETIC
TRAINING 299, 299 (2010) (explaining that federal and state laws direct prescription and over-thecounter drug dispensation and administration); see also John Goetz & Donald Lund, What the Law
Allows, PHARMACEUTICAL EXECUTIVE, Aug. 2000, at 76, 78, 82 (addressing the state and federal
statutes that govern online pharmaceutical sales).
118. See 21 U.S.C. § 801 (2006).
119. Id. § 841. Controlled substances are the drugs listed in Schedules I through V of the
Controlled Substances Act. Id. §§ 811–812. Illegal drug use is the use of a controlled substance not
in accordance with a valid prescription. See 10 C.F.R. § 707.4 (2012).
120. See supra notes 51, 57 and accompanying text (explaining that Adderall and Ritalin are
Schedule II drugs and Provigil is a Schedule IV drug). The Controlled Substances Act does not
apply to beta blockers. See supra note 67 and accompanying text. As Schedule II drugs, Adderall
and Ritalin prescriptions are limited to thirty days worth of doses with no automatic refills. DeSantis
et al., supra note 81, at 320 (noting that these medications are also subject to DEA production
quotas). As a Schedule IV drug, Provigil is not restricted in its production; instead, the DEA places
restraints on its manufacture and distribution. RICHARDS, supra note 2, at 164.
121. See 21 U.S.C. § 841 (2006); see also supra note 117 and accompanying text. While
penalties vary depending on the amount of medication and its schedule classification, imprisonment
ranges from one year to life and fines from $100,000 to $50,000,000, with penalties doubling for
second offenses. See 21 U.S.C. § 841. Federal law also prohibits buying controlled substances
online without a valid prescription and recognizes the importation of drugs into the United States as
a felony. Goetz & Lund, supra note 117, at 78; see also Consumer Alert, Prescription Drugs:
Buying On-Line Could Mean Doing Time, DEA OFFICE OF DIVERSION CONTROL,
www.deadiversion.usdoj.gov/consumer_alert.htm (last visited Mar. 1, 2012) (warning that most
rogue pharmaceutical websites are usually based in foreign countries). A 2008 study found that 85%
of all websites that sold medications required no physician’s prescription, making the illicit nature of
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as per se ethics violations.122 But ethical lines begin to blur when brainboosting users obtain legal prescriptions for off-label purposes, and the real
question becomes whether “legal” use is unethical when students pop
cognitive enhancers for medical and law school examinations.123
When debating the ethical implications of cognitive enhancement by
society at large, proponents and critics commonly focus on three concerns:
safety concerns, social implications, and fairness issues.124 These categories
provide an apt framework for the analysis of brain boosting within a
narrower segment of society—the classrooms of medical and law school
universities.125
A. Look Who’s Doping: Safety Concerns with Scholastic Steroids
The Federal Food, Drug, and Cosmetic Act requires that drug
manufacturers establish that medications are safe for their intended
purposes.126 However, the law permits physicians to prescribe drugs for off-

online drug sales apparent. Bryan A. Liang & Tim Mackey, Searching for Safety: Addressing
Search Engine, Website, and Provider Accountability for Illicit Online Drug Sales, 35 AM. J.L. &
MED. 125, 126 (2009). For example, one recent survey of 1811 students at a large public university
discovered that 34% of the students who reported taking stimulants for cognitive enhancement
claimed to use such prescription medications illegally. DeSantis & Hane, supra note 79, at 32.
122. See generally CODE OF MEDICAL ETHICS OP. 8.15 (1986) (addressing substance abuse
among doctors); MODEL CODE OF PROF’L CONDUCT R. 8.4(b) (2010) (discussing professional
misconduct among lawyers). The AMA also discourages doctors or student doctors from selfprescribing or prescribing for their peers. See CODE OF MEDICAL ETHICS OP. 8.19 (1993); CODE OF
MEDICAL ETHICS OP. 8.191 (2008).
123. See Fenton & Wunderlich, supra note 44, at 17. This ethical analysis should focus on the
subjective intent of the drug takers, or the medical and law school students “who ‘game’ the system
to get legally—yet ethically questionable”—prescription medications. Id. As one journalist
summarized, “In the real world, there are no rules to prevent overachievers from using legally
prescribed drugs to operate at peak mental performance.” Kaplan & Gellene, supra note 72 (asking
what patient would not want his or her surgeon to be at such a level for life-or-death procedures).
124. See, e.g., Fox, supra note 56, at 1146–49; Greely, supra note 6, at 1148. For instance, a
commentator explained, “While [cognitive-enhancement drug] use is not inherently unethical, steps
must be taken to ensure that they are safe, that they are widely available to promote equality of
opportunity, and that individuals are free to decide whether or not to use them.” Mehlman, supra
note 13, at 483.
125. See supra text accompanying notes 113–15.
126. 21 U.S.C. § 355(b)(1) (2006). Congress passed the Food, Drug, and Cosmetic Act in 1938
to ensure that the FDA had the authority to conduct pre-market safety reviews for all “new drugs.”
Victor E. Schwartz et al., Marketing Pharmaceutical Products in the Twenty-First Century: An
Analysis of the Continued Viability of Traditional Principles of Law in the Age of Direct-toConsumer Advertising, 32 HARV. J.L. & PUB. POL’Y 333, 339 (2009) (providing a detailed history
behind the Act); see also Michelle Meadows, A Century of Ensuring Safe Foods and Cosmetics,
FDA CONSUMER, Jan.–Feb. 2006, at 6, 8–9 (explaining the Act’s impact on drug and food
regulation). Although the Act represents federal law, more than half of the states have adopted a
Uniform State Food, Drug, and Cosmetic Bill, closely patterned after the federal act. Developments
in the Law—The Federal Food, Drug, and Cosmetic Act, 67 HARV. L. REV. 632, 636 (1954); see
also JOHN E.H. SHERRY, THE LAWS OF INNKEEPERS—FOR HOTELS, MOTELS, RESTAURANTS, AND
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label reasons, although manufacturers have not submitted any “safety or
efficacy data to the FDA substantiating the so-called off-label use.”127 This
means cognitive enhancement—an unapproved, unsubstantiated, nontherapeutic purpose128—may pose unknown safety risks, including adverse
side effects, addictive propensities, other long-term dangers, and
personalized research hazards.129 For example, the World Anti-Doping
Agency (WADA) already prohibits all four types of cognitive enhancers in a
variety of sports, primarily relying on their actual or potential risks to an
athlete’s health, rather than their ability to create unfair advantages.130

CLUBS 633 (3d ed. 1993) (explaining that the federal law does not completely preempt state law as
long as the states do not contravene the federal act).
127. Mehlman, supra note 13, at 486 (“Organized medicine has staunchly defended this
prerogative as an exercise of professional autonomy within the practice of medicine, a realm that the
FDA has long acknowledged lies outside the scope of its authority.”). Although the law does restrict
manufacturers’ abilities to promote off-label medicinal use, the practice still persists. Marc A.
Rodwin, Drug Advertising, Continuing Medical Education, and Physician Prescribing: A Historical
Review and Reform Proposal, 38 J.L. MED. & ETHICS 807, 809 (2010); see, e.g., Stix, supra note
101, at 55 (explaining that Cephalon already paid nearly $444 million to two states and the federal
government for its illegal promotion of Provigil for unapproved uses); supra note 92 and
accompanying text (noting Cephalon’s off-label marketing of Provigil); see also Michael Jon
Andersen, Bound Guidance: FDA Rulemaking for Off-Label Pharmaceutical Drug Marketing, 60
CASE W. RES. L. REV. 531, 532 (2010) (“[D]espite the marketing restrictions, manufacturers utilize a
number of methods to promote off-label uses of pharmaceuticals, including paying for professional
education sessions, hiring speakers, engaging in direct mail campaigns, and reprinting favorable
journal articles.”).
128. See supra text accompanying note 69 (noting that FDA-approved uses do not include
cognitive enhancement).
129. See Greely, supra note 49, at 129–30 (stating that safety concerns are the strongest
arguments against medicinal cognitive enhancement). “‘It would be wonderful if one could take a
drug and be smarter, faster, or have more energy,’ said Nora Volkow, director of the National
Institute on Drug Abuse . . . . ‘But that is like fairy tales. We currently have nothing that has those
benefits without side effects.’” Carla K. Johnson, The Downside of ‘Smart Drug’: Study Finds It
May Be Addictive, STAR-LEDGER, Mar. 18, 2009, at 9, available at 2009 WLNR 5142091.
130. Cakic, supra note 71, at 613 (“Caffeine, for example, reliably increases performance in a
range of sports including swimming, cycling and running at doses allowed by WADA. Yet despite
being a form of ‘cheating’ in the same vein as anabolic steroids, caffeine’s use in sport is permitted
because it is relatively harmless.”). See generally The World Anti-Doping Code: The 2011
Prohibited List—International Standard, WORLD ANTI-DOPING AGENCY (Sept. 18, 2010), available
at http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/To_
be_effective/WADA_Prohibited_List_2011_EN.pdf (noting that this list took effect January 1,
2011). WADA prohibits Adderall, Ritalin, and Provigil for all in-competition situations but it bans
beta blockers only for sixteen in-competition sports and two out-of-competition and in-competition
categories—archery and shooting. Id. at 7–9.
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1. Adverse Side Effects
Possible side effects of cognitive enhancers vary depending on the
medication. Adderall and Ritalin commonly cause dizziness, irritability,
headache, appetite suppression, and insomnia.131 Their more serious side
reactions include stroke, seizure, heart attack, blurred vision, psychiatric
disturbance, and death.132
While Provigil chemically works in a similar manner as Adderall and
Ritalin,133 its common side effects are less severe: back pain, stuffy nose,
and upset stomach.134 Provigil’s more serious potential side effects include
psychiatric experiences, heart difficulties, and rashes that require

131. MEDICATION GUIDE: ADDERALL XR, supra note 48, at 3; MEDICATION GUIDE: RITALIN,
supra note 48, at 2; see also Johnny Graham & David Coghill, Adverse Effects of
Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: Epidemiology, Prevention and
Management, 22 CNS DRUGS 213, 216 (2008) (analyzing numerous studies that largely agree on the
common adverse effects of stimulant medications). But see Madhiraju, supra note 36, at 1666
(noting that Ritalin’s common side effects of headache, insomnia, and loss of appetite usually
dissipate quickly). Ritalin’s other possible adverse reactions include a decreased ability to learn,
social withdrawal, abdominal pain, extensive bruising, and abnormally low white and red blood cell
counts. Szuflita, supra note 36; see also Chiumino, supra note 12, at 383 (warning that children also
may develop Tourette’s Syndrome).
132. Schieffelin, supra note 13, at 973. See also Gardiner Harris, Warning Urged on Stimulants
Like Ritalin, N.Y. TIMES (Feb. 10, 2006), http://www.nytimes.com/2006/02/10/health/policy/
10drug.html?pagewanted=all (explaining that reports of sudden death have never exceeded one in a
million for any stimulant drug). In 2004, more than 3000 people visited hospital emergency rooms
because of adverse reactions from AD/HD medications. Miranda Hitti, ADHD Drugs Tied to ER
Visits, WEBMD HEALTH NEWS (May 25, 2006), http://www.webmd.com/add-adhd/news/20060525/
adhd-drugs-tied-to-er-visits (noting that most of the cases requiring hospitalization were linked to
inappropriate use of the stimulant drugs). In 2006, a federal advisory panel recommended that drug
manufacturers place prominent warnings describing their possible dangerous cardiac effects on
AD/HD medication labels. Harris, supra (“[The committee] voted 8 to 7 to suggest that stimulant
labels carry the most serious of the agency’s drug-risk warnings—a ‘black box.’”). Both the
Adderall and Ritalin medication guides already caution that people who are very agitated, anxious,
or tense should not take these stimulants, thereby warning against consumption by most medical and
law school students. See MEDICATION GUIDE: ADDERALL XR, supra note 48, at 1; MEDICATION
GUIDE: RITALIN, supra note 48, at 2.
133. See supra note 56 and accompanying text.
134. MEDICATION GUIDE: PROVIGIL, supra note 54, at 39; see also Yaron Dagan & Julia T.
Doljansky, Cognitive Performance During Sustained Wakefulness: A Low Dose of Caffeine Is
Equally Effective as Modafinil in Alleviating the Nocturnal Decline, 23 CHRONOBIOLOGY INT’L 973,
974 (2006) (observing that Provigil’s mild side effects are only expressed at high doses—usually
requiring more than 600 milligrams).
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hospitalization.135 In actuality, Provigil’s adverse side effects “are rarely
worse than a mild headache or slight nausea.”136
Lastly, beta blockers commonly engender dizziness, fatigue, and cold
hands.137 Their less recognized reactions include loss of sex drive, breathing
difficulties, insomnia, abdominal cramping, hallucination, and short-term
memory loss.138 Although Provigil and beta blocker consumption rarely
pose serious safety concerns—unlike Adderall and Ritalin139—all four
cognitive enhancers can create severe complications, including heart
problems, psychiatric experiences, and death.140
2. Abuse Potentials
These cognitive enhancers also differ in their potential for abuse or
addiction.141 Adderall, Ritalin, and Provigil are federally-specified schedule
drugs, or federally controlled substances, because they can encourage abuse
or dependence.142 As Schedule II medications, Adderall and Ritalin exhibit
a high potential for prompting severe physical and psychological

135. MEDICATION GUIDE: PROVIGIL, supra note 54, at 39; Cephalon Response to the March 18,
2009, JAMA Article, “The Effects of Modafinil on Dopamine and Dopamine Transporters in the
Male Human Brain,” CEPHALON (Mar. 2009), http://www.cephalon.com/media/on-therecord/cephalon-response-to-march-18-2009-jama-article-the-effects-of--modafinil-on-dopamineand-dopamine-transporters-in-the-male-human-brain.html (additionally listing chest pain, breathing
difficulty, hallucination, aggression, and suicidal thoughts).
136. O’Connor, supra note 55 (noting that in clinical trials, only about one percent of patients
complained of any side effects). Most Provigil users do not even experience the jitteriness
associated with amphetamines. Osborn, supra note 55, at 334. At an advisory panel meeting in
2003, FDA officials even suggested “they were not overly concerned” with Provigil use by healthy
adults because it was “generally safe.” Andrew Pollack & Alicia Ault, Advisory Panel Endorses
More Uses for Stimulant, N.Y. TIMES (Sept. 26, 2003), http://www.nytimes.com/2003/09/26/
business/advisory-panel-endorses-more-uses-for-stimulant.html.
137. MEDICATION GUIDE: LOPRESSOR HCT, supra note 65, at 7–8 (noting that adverse effects are
“mild and transient”); MEDICATION GUIDE: TOPROL-XL, supra note 66, at 13; see also Sigman,
supra note 58, at 157. Beta blockers can make users tired or dizzy by slowing or weakening their
heartbeat. Catherine Nelson, The Taboo Tablet: Drugs and Performance, STRAD, Aug. 2010, at 24,
26. These medications can also cause cold hands and feet by constricting small blood vessels and,
consequently, reducing the blood’s circulation to these limbs. Id. Generally, any unwanted effects
are uncommon. Kelly, supra note 108, at 149.
138. Sigman, supra note 58, at 157; see also Inderal, supra note 63.
139. See supra notes 131, 134, 137 and accompanying text.
140. See supra notes 132, 135, 138 and accompanying text.
141. See supra notes 49, 57, 67 and accompanying text.
142. See supra note 120 and accompanying text. Schedules are federally-imposed classifications
of drugs that are popular for addictive or recreational use. Greely, supra note 49, at 115 (noting that
federal law requires special handling and paperwork requirements for scheduled medications).
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dependence.143 Provigil, a Schedule IV medication, is said to have a lesser
potential for abuse and may lead to dependence in only some users.144
However, recent scientific studies have found that Provigil chemically binds
to the same dopamine transporter sites as cocaine and Ritalin—leaving its
abuse potential in question.145 In contrast, beta blockers are not federally
controlled substances because they present zero addiction potential.146 They
also tend to be fairly safe147 and relatively inexpensive.148
3. Long-Term Dangers
Regardless of their differing potentials for dependence,149 cognitiveenhancement medications can create undesirable risks if non-addicted
143. See supra note 49. Dependence leads to extended stimulant use or abuse, which can create
numerous adverse reactions. See infra notes 156–57 and accompanying text. Besides a high abuse
potential, stimulant medications also induce unpleasant withdrawal effects. Vliet et al., supra note
90, at 60. Physical dependence generates withdrawal symptoms when drug use is stopped.
RICHARDS, supra note 2, at 174.
144. See supra note 57 and accompanying text. For instance, after Hari experimented with
Provigil for five days and decided to take a three-day break, he reported he “painlessly sagged back
to [his] former somewhat-depleted state, as though the Provigil had never happened.” Hari, supra
note 95; see also supra note 95 and accompanying text (recounting Hari’s short experience with
Provigil). Nonetheless, he also wrote that he “stared sadly at the pack of Provigil, and every time
[he] hit a mental stumbling block, [he] had to discipline [himself] not to crack out a Provigil.” Hari,
supra note 95.
145. See supra notes 56–57; see also Raminder Kumar, Approved and Investigational Uses of
Modafinil: An Evidence-Based Review, 68 DRUGS 1803, 1828–29 (2008) (describing a recent study
where Provigil had a similar profile as Ritalin). But see Volkow et al., supra note 56, at 1152–53
(noting that reports of Provigil abuse are rare and less frequent than those for Adderall and Ritalin).
However, one psychiatrist said he has treated three cases of Provigil addiction—“I had two doctors
back-to-back who were addicted . . . [to Provigil], so I became alarmed . . . .” Rita Rubin, A
Warning on Off-Label Use of Sleep-Disorder Drug, USA TODAY (Mar. 17, 2009),
http://www.usatoday.com/news/health/2009-03-17-awake-modafinil_N.htm (explaining that drugs
that increase dopamine levels have potential for abuse). In July 2010, the European Medicines
Agency recommended that Europeans only use Provigil to treat sleepiness associated with
narcolepsy; the Agency presented this advisement to the European Commission after concluding that
Provigil’s medicinal risks outweighed any other beneficial purpose. See Press Release, European
Meds. Agency, European Meds. Agency Recommends Restricting the Use of Modafinil (July 22,
2010), available at http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2010/
07/WC500094976.pdf (noting safety concerns that related to psychiatric disorders, skin reactions,
potential for abuse, and significant off-label use).
146. See supra note 67 and accompanying text. Nevertheless, extended beta blocker use may still
cause adverse side effects. See infra notes 161–62 and accompanying text.
147. SYNCOPE: MECHANISMS AND MANAGEMENT 60 (Blair P. Grubb & Brian Olshansky eds., 2d
ed. 2005). Contra infra notes 174–77 and accompanying text (describing the effects of beta blocker
poisonings).
148. Beta blockers usually are the cheapest cognitive-enhancement medications; for example,
drugstore.com sells 100 twenty-milligram tablets of propranolol hcl for $13.99—about 14¢ per pill.
http://www.drugstore.com/propranolol-hcl/inderal/
Propranolol
Hcl,
DRUGSTORE.COM,
20mg-tablets/qxn23155011110 (last visited Mar. 1, 2012); see also supra note 96 (noting, in
contrast, that drugstore.com sells Provigil for $26.61 per pill).
149. See supra text accompanying note 141.
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students voluntarily take them over a protracted time.150 While students
usually complete medical and law school educations within three or four
years,151 they may not stop taking brain boosters upon graduating if their
high-pressured professions seem to demand the enhanced capabilities the
Both brain-boosting critics and proponents
drugs can provide.152
acknowledge a lack of concrete information about the long-term use of
cognitive enhancers by healthy adults—leaving medicinal mental doping in
a state of dangerous uncertainty.153 Questions remain as to whether
extended use actually diminishes vital aspects of intellectual activity—such
as verbal fluency, creativity, and abstract thinking—through cognitive
constriction.154 “[I]t remains to be seen whether [cognitive enhancers]

150. See Mehlman, supra note 13, at 485 (arguing that deleterious side effects may be
exacerbated by long-term use).
151. See U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-10-412, FOREIGN MEDICAL SCHOOLS:
EDUCATION SHOULD IMPROVE MONITORING OF SCHOOLS THAT PARTICIPATE IN THE FEDERAL
STUDENT LOAN PROGRAM 20 (2010), available at http://www.gao.gov/assets/310/306021.pdf
(noting that most U.S. medical school programs last four years and some foreign programs last
three); William D. Henderson, The LSAT, Law School Exams, and Meritocracy: The Surprising and
Undertheorized Role of Test-Taking Speed, 82 TEX. L. REV. 975, 998, 1023 (2004) (observing that
law school programs usually last three years).
152. See Mehlman, supra note 13, at 485. “Even if the use of cognitive enhancements is not
explicitly mandated, people may feel that they must do so in order to succeed or just to stay where
they are in competitive endeavors.” Id. at 488. Another commentator warned against the future of
employment discrimination, where students must either continue to enhance their brains for
employers who expect the same output they demonstrated in school or endure discrimination
because of their lessened cognitive abilities. See J.M. Appel, When the Boss Turns Pusher: A
Proposal for Employee Protections in the Age of Cosmetic Neurology, 34 J. MED. ETHICS 616, 617
(2008); see also Megan Ogilvie, Stronger, Faster, Smarter?, TORONTO STAR (Feb. 2, 2008),
http://www.thestar.com/News/article/299706 (explaining that employees may use cognitive
enhancers to work better, faster, and longer, and to keep up with other colleagues who also consume
brain boosters).
153. Daniel J. DeNoon, Brain-Boosting Drugs FAQ: What You Must Know, WEBMD HEALTH
NEWS (Dec. 11, 2008), http://www.webmd.com/brain/news/20081211/brain-boosting-faq-what-youmust-know (observing that scientists recommend “[a]ccelerated research into the risks and benefits
of cognitive enhancement”); see, e.g., Watts, supra note 58 (asserting that research has yet to
determine the consequences of long-term beta blocker use by the healthy). A shortage of focused
research hampers not only the understanding of long-term effects of these drugs but also the
development of more effective cognitive enhancers. Nick Jackson, Against the Grain: ‘The Benefits
of Brain-Boosting Drugs Are Huge,’ INDEP. EDUC. (May 29, 2008), http://www.independent.co.uk/
news/education/higher/against-the-grain-the-benefits-of-brainboosting-drugs-are-huge-835576.html.
One neuroscientist at Brown University Medical School explained, “There are lots of quick and dirty
studies of cognitive enhancement that make the news, but the number of rigorous, well-designed
studies that will stand the test of time is much smaller . . . . We’re sort of in the Wild West.” Sharon
Begley, Can You Build a Better Brain?, NEWSWEEK, Jan. 2011, at 40.
154. Jacquelyn H. Flaskerud, American Culture and Neuro-Cognitive Enhancing Drugs, 31
ISSUES MENTAL HEALTH NURSING 62, 63 (2010); see also Goodman, supra note 81, at 148
(discussing the concerns with hampered lateral thinking). Cognitive constriction is the “narrowing
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represent a pharmacological ‘free lunch’ or if the enhancement of some
cognitive functions can only be realized at the expense of others.”155
For Adderall and Ritalin, the nationwide McCabe survey found longterm, non-medical prescription stimulant consumers were “more likely to
report use of alcohol, cigarettes, marijuana, ecstasy, cocaine, and other risky
behaviors.”156 Moreover, extensive abuse of stimulant medications can
encourage nervous system anomalies, extreme depression, seizures,
schizophrenia, and toxic psychosis.157 Although doctors consider Provigil
less harmful than stimulants,158 some scientists declare that its long-term
manipulation of the sleep system can have dire consequences.159 Chronic
sleep deprivation weakens the immune system, damages health, increases
the likelihood of disease, and is linked to a shorter life span.160 Finally, for
beta blocker consumption, studies demonstrate that extended use causes
such adverse effects as depression, nightmares, wheezing, sexual

of attentional focus, such that stimuli which are ‘peripheral’ in space, time, or meaning to the subject
are relatively ignored.” Mary V. Solanto, Dosage Effects of Ritalin on Cognition, in RITALIN:
THEORY AND PATIENT MANAGEMENT 233, 240 (Laurence L. Greenhill & Betty B. Osman eds.,
1991). For example, a lawyer who took Provigil daily for several months said all his daydreaming,
extraneous thoughts, and distractions disappeared—leaving only complete concentration for the task
at hand. Madrigal, supra note 99. But one college student claimed stimulant medications made her
feel more creative, focused, and energetic. Id. (explaining how Adderall helped her write a thirtyfive-page thesis in less than twelve hours). Many critics of cognitive enhancement suggest that
unknown future harms outweigh any short-term intellectual benefits. Appel, supra note 152, at 617.
155. Cakic, supra note 71, at 613. The executive director of the Neurotechnology Industry
Organization warned that poor research on healthy adult consumption means consumers may not
notice serious side effects of cognitive enhancers until at least twenty years down the road. Kirby,
supra note 7, at 94.
156. McCabe et al., supra note 80, at 96; see also supra note 80 and accompanying text
(describing the survey’s general results).
157. See Madhiraju, supra note 36, at 1667; Pavisian, supra note 42, at 179. Toxic psychosis is a
“severe mental illness in which the patient loses contact with reality.” BANTAM MEDICAL
DICTIONARY 358 (rev. ed. 1990).
158. See supra note 94 and accompanying text.
159. O’Connor, supra note 55; see also Szuflita, supra note 36 (“[A]buse of such drugs can lead
to serious sleep deprivation in a demographic group that is already very sleep deprived.”). Dr. David
Slamowitz, a sleep disorder specialist, cautioned, “‘People think they can now burn the candle at
both ends and not have to pay for it if they take this drug’ . . . . But even if a person doesn’t feel the
need for sleep . . . doing without it can be harmful.” Pollack, supra note 88, at 31.
160. O’Connor, supra note 55. But see Vliet et al., supra note 90, at 59 (recommending wakepromoting drugs to combat the detrimental consequences of sleepiness). Skimping on sleep affects a
person’s judgment; for example, many blame the lack of sleep for such disasters as the Exxon
Valdez oil spill, Chernobyl nuclear meltdown, and the space shuttle Challenger incident. O’Connor,
supra note 55. In terms of mental impairment, eighteen hours of no sleep is equivalent to a 0.05
blood alcohol level; twenty-one hours of no sleep is equivalent to a 0.08 blood alcohol level—which
is illegal when driving in most states. Id. (quoting the director of the University of Michigan’s sleep
disorders center).
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dysfunction, and light-headedness.161 Rarer reactions include weight gain,
hypotension, and increased risk of new-onset diabetes.162
4. Personalized Research Risks
The final safety concern for medicinal cognitive enhancement is the risk
inherent in personalized research, or self-experimentation,163 where
individuals try different dosages and methods of administration “in a wild,
crowdsourced, ad hoc brain-enhancement experiment.”164 Because cognitive
enhancement is an off-label purpose, the FDA does not require drug
manufacturers to set dosages and methods for this type of use—leaving
consumers to discover their own personal drug regimens.165 Even in the face
of hazardous uncertainty, these consumers still readily embark on such a
precarious path:
It’s hard to know exactly how many healthy adults are doping their
brains.
Anecdotal evidence on the Internet suggests an
underground enhancement culture is taking shape not unlike what
occurred in the early days of steroid use in bodybuilding. In online
forums devoted to cognition enhancement, participants rhyme off
their pharmaceutical regimens the same way other people swap

161. F.H. Messerli et al., Cardioprotection with Beta-Blockers: Myths, Facts and Pascal’s
Wager, 266 J. INTERNAL MED. 232, 239 (2009); see, e.g., Watts, supra note 58 (describing an
incident where a doctor passed out during his presentation after taking a beta blocker for stage
fright). A 1998 research study confirmed that some beta blockers can decrease sexual libido and
even cause impotence with long-term use. R. Fogari et al., Libido Decreases with Long-Term BetaBlocker Use, 11 AM. J. HYPERTENSION 1244, 1244 (1998); see also Paul C. Ajamian, Beta-Blockers:
Treat with Care, REV. OPTOMETRY, Feb. 2001, at 89, 89 (recommending that physicians advise male
patients that beta blocker consumption may affect their sexual performances).
162. Messerli et al., supra note 161, at 239.
163. See THE OXFORD ILLUSTRATED COMPANION TO MEDICINE 744–45 (Stephen Lock et al.
eds., 3d ed. 2001) (“Observing and measuring the effects on oneself of ingested or injected drugs
have long been mainstays of experimental pharmacology.”).
164. Madrigal, supra note 99 (listing more than fifteen different drug regimens from students,
scientists, and executives). For example, a scientist at the MIT-affiliated Whitehead Institute for
Biomedical Research explained how he experimented with Provigil dosages over several weeks:
“200 mg in the morning, 100 mg, 50 mg, 10 mg, and then split doses of more in the morning and a
reduced dose at lunch.” Id. A wireless ISP owner said his drug regimen was half a Provigil tablet
and three gingko capsules in the mornings—to activate his triple espresso. Id. Lastly, a Florida
college student claimed that taking thirty-milligram Adderall XR improved his focus, attention to
detail, and test scores. Id.
165. See supra notes 69, 127–28 and accompanying text. This lack of FDA oversight may
explain why a recent survey among doctors found that “they’re more comfortable prescribing sex
drugs than smart drugs.” Begley, supra note 153, at 41.
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cocktail recipes. Except in this case, the ingredients are some of the
most powerful compounds on the market, approved to treat not just
narcolepsy and attention deficit disorder, but also Parkinson’s
disease, Alzheimer’s and depression.166
The two most notable dangers of self-experimentation are drug
overdose167 and unforeseeable medicinal interactions.168 Overdosing can be
accidental or premeditated.169 For stimulant users, most overdosing is
probably premeditated because unintentional overdosing on the
recommended amount is a rare occurrence.170 When acute Adderall
overdose does occur, it can result in hypertension, seizure, hyperthermia,
hallucination, stroke, or death.171 Similarly, Ritalin overdose can cause
irregular heartbeat, seizure, and cardiac failure.172 Provigil overdose has less
severe consequences—such as nausea, diarrhea, confusion, and
hallucination.173 Lastly, beta blockers vary in their acute overdose potential

166. Kirby, supra note 7, at 94.
167. DeNoon, supra note 153. Overdosing is “a result of ‘super dosage’ in the use of one or
more substances that trigger physiological alterations which can seriously compromise the user’s
health and require immediate medical attention to avoid death.” Eroy Aparecida da Silva et al.,
Death by Drug Overdose: Impact on Families, 39 J. PSYCHOACTIVE DRUGS 301, 302 (2007).
168. Barbara Sahakian & Sharon Morein-Zamir, Professor’s Little Helper, 450 NATURE 1157,
1158 (2007) (explicitly not advocating self-medication because of potential drug interactions).
169. Silva et al., supra note 167, at 303 (noting that unintentional “super dosage” occurs (1) when
compulsive drug use leads consumers to lose awareness of their past ingestion or (2) when drugs
contain unexpectedly high lethal potentials).
170. See Robert M. Diener, Toxicology of Ritalin, in RITALIN: THEORY AND PATIENT
MANAGEMENT 35, 42 (Laurence L. Greenhill & Betty B. Osman eds., 1991); Pavisian, supra note
42, at 179. For example, while a single recommended Adderall dosage is ten to thirty milligrams, a
person may need to consume 400 to 500 milligrams before a dose turns fatal. Pavisian, supra note
42, at 178–79. Overdosing on Adderall more easily occurs when users do not swallow extendedrelease Adderall XR tablets whole, but instead crush or chew them, because too much of the drug
enters a body’s biological system at one time. See MEDICATION GUIDE: ADDERALL XR, supra note
48, at 2. If consumers cannot swallow Adderall XR capsules, the medication guide recommends
they open the capsules, sprinkle the medicine on a spoonful of applesauce, and swallow all the
applesauce without chewing. Id. Although overdose potential is low for recommended doses,
prolonged stimulant use can create dependence and tolerance that may necessitate higher doses to
achieve desired effects. See Pritesh J. Gandhi et al., Myocardial Infarction in an Adolescent Taking
Adderall, 62 AM. J. HEALTH-SYS. PHARMACY 1494, 1494 (2005).
171. Gandhi et al., supra note 170, at 1494. However, statistical reports suggest most Adderallrelated deaths result from chronic or extended consumption, not acute toxicity. Steven Karch, The
Problem of Methamphetamine Toxicity, 170 W. J. MED. 232, 232 (1999).
172. Diener, supra note 170, at 42. Mild Ritalin overdoses potentially foster insomnia,
nervousness, hypersensitivity, anorexia, palpitations, drowsiness, headache, blood pressure changes,
and abdominal pain. Id.
173. Provigil, supra note 54; see also MEDICATION GUIDE: PROVIGIL, supra note 54, at 39.
Contra Kumar, supra note 145, at 1804 (asserting that Provigil has “serious dermatological
toxicity”). Provigil overdose is infrequent and rarely life threatening. Henry A. Spiller et al.,
Toxicity from Modafinil Ingestion, 47 CLINICAL TOXICOLOGY 153, 155 (2009). While 137 Provigil
overdoses were reported at fifteen poison centers from eleven states during an eight-year period,
intentional abuse occurred in only seven of those cases. Id.

1018

DO NOT DELETE

[Vol. 39: 989, 2012]

4/20/2012 1:33 PM

Scholastic Steroids
PEPPERDINE LAW REVIEW

with Inderal predominantly provoking the most beta blocker poisonings.174
However, overdosing on Inderal, Lopressor, or Toprol-XL can all lead to
seizure, bronchospasm,175 hypotension,176 and cardiac failure.177
Besides the possibility of an overdose, self-experimenting with
cognitive enhancers can result in unanticipated interactions with other drugs
or substances.178 For instance, the medication guides for Adderall, Ritalin,
and Provigil warn that interactions with other prescriptions may engender
serious side effects.179 FDA-approved medication guides also advise
Provigil and beta blocker patients to avoid alcohol.180 Lastly, the beta
blocker medication guides specifically list other drugs that inhibit or
exacerbate medicinal effects with concurrent use.181
While risks are inherent with all medications, the fact that healthy
individuals consume cognitive enhancers for mental enhancement rather

174. Sharma et al., supra note 63; see also Jeffrey N. Love et al., Acute Beta Blocker Overdose:
Factors Associated with the Development of Cardiovascular Morbidity, 38 CLINICAL TOXICOLOGY
275, 277 (2000) (finding that Propanalol was implicated in 121 of 280 beta blocker overdoses).
Possible overdose is more common with beta blockers than with other cognitive enhancers; for
example, in 1997, consumers reported 8553 beta blocker exposures to the American Association of
Poison Control Centers (AAPCC). Love et al., supra, at 278–79; see also supra notes 170, 173 and
accompanying text (describing smaller overdose rates for the other cognitive enhancers).
175. Bronchospasm is the spasmodic narrowing of the windpipe. STEDMAN’S MEDICAL
DICTIONARY, supra note 51, at 197.
176. Hypotension is low blood pressure. Id. at 682.
177. See MEDICATION GUIDE: INDERIDE, supra note 63, at 10; see also David M. Reith &
Andrew H. Dawson, Relative Toxicity of Beta Blockers in Overdose, 34 J. TOXICOLOGY 273, 273
(1996). In 2003, consumers reported 15,350 beta blocker exposures—including 2163 severe
overdose cases—to the AAPCC; of these, thirty-three resulted in death. Joel S. Holger et al., A
Comparison of Vasopressin and Glucagon in Beta-Blocker Induced Toxicity, 44 CLINICAL
TOXICOLOGY 45, 45 (2006).
178. DeNoon, supra note 153; see also Syed F. Ali & S.C. Bondy, Red Wine But Not Ethanol at
Low Doses Can Protect Against the Toxicity of Methamphetamine, BRAIN RES., July 30, 2010, at
247, 248 (explaining that drug abusers often consume several substances in conjunction).
179. See MEDICATION GUIDE: ADDERALL XR, supra note 48, at 1; MEDICATION GUIDE:
PROVIGIL, supra note 54, at 37; MEDICATION GUIDE: RITALIN, supra note 48, at 1. These guides
caution consumers to tell their doctors about all medicinal use—including prescriptions, vitamins,
herbal supplements, and nonprescription medications. See MEDICATION GUIDE: ADDERALL XR,
supra note 48, at 1–2; MEDICATION GUIDE: PROVIGIL, supra note 54, at 37; MEDICATION GUIDE:
RITALIN, supra note 48, at 1–2.
180. See MEDICATION GUIDE: INDERIDE, supra note 63, at 7; MEDICATION GUIDE: PROVIGIL,
supra note 54, at 39 (“It is not known how drinking alcohol will affect you when taking
PROVIGIL.”).
181. See MEDICATION GUIDE: INDERIDE, supra note 63, at 6–7 (listing such medications as
catecholamine-depleting drugs, calcium-channel blocking drugs, nonsteroidal anti-inflammatory
drugs, and aluminum hydroxide gel); MEDICATION GUIDE: LOPRESSOR HCT, supra note 65, at 5
(also including clonidine and general anesthetics); MEDICATION GUIDE: TOPROL-XL, supra note 66,
at 11 (further listing digitalis glycosides and CYP2D6 inhibitors).
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than medical treatment may indicate that any type of risk is unacceptable.182
However, the true exercise of personal autonomy requires individuals who
are aware of the possible safety concerns to make their own free-will
decisions.183 For example, in the recent Nature survey, questioning 1400
academics from sixty countries, half of the respondents who took cognitive
enhancers for non-medical purposes reported unpleasant side effects, but
only some chose to discontinue use.184 Sixty-nine percent of all surveyed
stated they would risk mild side effects for the cognitive-enhancement tradeoff, and 80% thought healthy adults should have the choice to participate in
brain-boosting use.185 Generally, some ethicists argue that civil liberties
should outweigh theoretical safety hazards, especially those created when

182. Cakic, supra note 71, at 613; see also Sahakian & Morein-Zamir, supra note 168, at 1157
(“For all medications, the chief concern cautioning against their use is adverse side effects that affect
the individual’s health and well being [sic].”). Acceptable safety risks depend on the potential
benefits, which understandably are slim for already healthy individuals. See Greely et al., supra note
9, at 703; see also Michael K. Ahlijanian, Eschew Enhancement: Memory-Boosting Drugs Should
Not Be Made Available to the General Public, TECH. REV. (May 1, 2009),
http://www.technologyreview.com/biomedicine/22476 (contending that the risks of harm
substantially outweigh any cognitive benefits).
183. Cakic, supra note 71, at 613; see also Enhancing, Not Cheating, 450 NATURE 320, 320
(2007) (describing the opponents of cognitive enhancement as “whistling in the wind” against the
opposing ethical argument of the “pursuit of personal liberty”). It would appear these two extremes
exist in an untenable compromise—where consumers have the right to decide if risks are acceptable,
but their “civil liberties must also be balanced by the need to safeguard the public good.” Cakic,
supra note 71, at 613. For illustration, one survey of 1811 students at an American public university
found that none of the interviewed respondents had “sought out information from health
professionals, medical or pharmaceutical reference guides, or even Internet sites” before taking their
first cognitive enhancer. DeSantis et al., supra note 81, at 317 (reporting that most first-time
cognitive-enhancement use occurred at times of high academic stress and anxiety). Further, the
researchers discovered that a majority of the student users possessed limited knowledge about the
cognitive enhancers they voluntarily consumed, with no understanding of their appropriate doses,
psychological or physiological side effects, or the legal ramifications of their illicit use. Id. at 320–
21 (finding that 96% of the student consumers had obtained their cognitive enhancers without
prescriptions). Such survey results may dictate a shift away from personal autonomy and towards
mandatory safeguards for the well-being of society. See Cakic, supra note 71, at 613.
184. Maher, supra note 98, at 674 (listing the reported side effects as headaches, anxiety,
jitteriness, and sleeplessness); see also supra note 98 and accompanying text (describing the
survey’s general results).
185. Maher, supra note 98, at 674. Academics that would employ cognitive enhancers,
notwithstanding their risks, follow an already established practice in athletics—where sports
competitors continue to take anabolic steroids, despite their serious adverse effects. Mehlman, supra
note 13, at 487. For example, one biannual study repeatedly reveals that more than half of the 200
world-class athletes interviewed “would take a drug that guaranteed them a gold medal but would
also kill them within five years.” Gretchen Reynolds, Phys Ed: Will Olympic Athletes Dope If They
Know It Might Kill Them?, N.Y. TIMES WELL BLOG (Jan. 26, 2010, 12:01 AM),
http://well.blogs.nytimes.com/2010/01/20/phys-ed-will-olympic-athletes-dope-if-they-know-itmight-kill-them (discussing the Goldman Dilemma survey). Surprisingly, a similar question asked
of nonathletes in a 2009 study reported that only two of the 250 respondents would take a
medication that would ensure both success and an early death. J.M. Connor & J. Mazanov, Would
You Dope? A General Population Test of the Goldman Dilemma, 43 BRIT. J. SPORTS MED. 871, 871
(2009) (only surveying Australians).
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healthy adults consume legally prescribed medications.186 But when these
adults are medical or law school students in an arena governed by ethical
codes, perhaps the scales tip toward mandatory safeguards.187 To fully
determine whether administrators and professional associations should be
tasked to monitor this medicinal practice, an ethical analysis must also
consider social implications and fairness concerns.188
B. All on Everyone’s Mind: Social Concerns with Prevalent Use
Cognitive enhancement in the medical and legal academic setting
creates a unique social ramification that is less prevalent or nonexistent in
other specialties—namely, social coercion.189 In many medical and law
schools, the educational stakes are high.190 Students work to outperform
their peers so they can earn high GPAs on tightly graded curves, to secure
the clinical or journal positions that will better position them to obtain the
limited career positions available in this increasingly competitive job
market.191 And if they do secure that coveted position at a “big name”
hospital or firm, the pressure to outperform may remain just as, or more,
intense.192 Individuals in these academic and professional settings often
186. RICHARDS, supra note 2, at 170, 184. Richards contends that personal autonomy means
healthy adults may consciously choose medicinal use to obtain a more fulfilling life:
It is, of course, a banality of the literature of perceptive observers on drug experience that
the quality of such experience varies according to the expectations, aims, and identity that
the person brings to the experience. This should confirm that drug experience is neither
satanic damnation nor divine redemption of the self, but merely one means by which the
already existing interests of the person may be explored or realized.
Id. at 170. If the interests of free will allow for unchecked medicinal cognitive enhancement,
physicians and consumers themselves can still act as the gatekeepers that prevent unsafe drug use.
See Mehlman, supra note 13, at 486. This presupposes that physicians and the general public are
making informed choices because they know the risk–benefit profiles of the cognitive enhancers
they either are prescribing or consuming. Id. But see supra note 183 and accompanying text
(discussing the possible ramifications from uninformed cognitive-enhancement use).
187. See supra notes 26–27 and accompanying text. For a setup of the ethical restrictions on both
medical and law school students and their respective professions, see supra notes 15–25 and
accompanying text.
188. See supra notes 124–25 and accompanying text.
189. See Cynthia Forlini & Eric Racine, Autonomy and Coercion in Academic “Cognitive
Enhancement” Using Methylphenidate: Perspectives of Key Stakeholders, 2 NEUROETHICS 163, 164
(2009) (explaining that the key concern is the degree of freedom that students have to abstain from
or engage in cognitive enhancement).
190. Id. at 167 (“In terms of grad studies, we’re getting into a highly competitive level where you
can be replaced at the snap of a finger purely based on grades.”).
191. See, e.g., id.; Webb et al., supra note 84, at 200 (describing medical school pressures).
192. See supra note 152 and accompanying text; see also Peter J. Whitehouse & Eric Juengst,
Enhancing Cognition in the Intellectually Intact, HASTINGS CENTER REP., May–June 1997, at 14, 21.
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experience social coercion—they think they must take brain boosters to
succeed or even stay on equal footing with their cognitively-enhanced
peers.193 This implicit coercion interferes with the exercise of free choice,
meaning that those who are opposed to using cognitive enhancers
themselves may either acquiesce to peer pressure or give up hopes of
academic and professional success.194 Those who ignore social coercion
may begin to resent their medicinal-using peers—creating more competitive
and stressful learning and working environments.195 Besides implicit
coercion, the prevalence of cognitive enhancement also may generate direct
coercion—leading parents196 and employers197 to strongly encourage
continued use for the sake of acquiring a consumer’s peak performance.198
193. See Greely, supra note 6, at 1150 (equating implicit coercion with competition); Mehlman,
supra note 13, at 488 (discussing the pressures and inducements of performance-enhancing drug
use). “So long as resources remain scarce and continue to be apportioned to such a large extent
competitively, this type of inducement will persist.” Mehlman, supra note 13, at 500. For example,
if most students use stimulants to vastly improve their grades, then the remaining nonusers may feel
pressure to follow suit if they wish to remain competitive. Cakic, supra note 71, at 612 (comparing
performance pressure in sports to cognitive pressure in schools).
194. Fox, supra note 56, at 1148. “Environments, like academia, can constitute ‘winner take all’
situations meaning that slight gains in cognitive performance can translate into substantial benefits.”
Forlini & Racine, supra note 189, at 164.
195. See Kaplan & Gellene, supra note 72 (quoting a professor who noticed resentment growing
among her students who refrained from cognitive enhancers). Abstaining students may resent their
peers because of the idea that their peers’ artificial study habits undermine the value of their natural
hard work. See id.
196. See Sarah Harris, Fears for ‘Smart Pill’ Generation, DAILY MAIL (London), Aug. 19, 2008,
at 60. Parental coercion has a long history with various levels of outrageousness. Greely, supra note
6, at 1151. Presently, evidence points to ambitious parents tackling the cognitive arena by buying
smart pills from the Internet for their studious children. See Marrin, supra note 77, at 65 (discussing
correlating safety concerns); see also Forlini & Racine, supra note 189, at 167 (interviewing parents
who felt the pressure to perform and succeed supported cognitive-enhancement practices). “These
pressures were often described as a demand for the individual to be the best in contrast to simply
being average.” Forlini & Racine, supra note 189, at 167.
197. See supra note 152 and accompanying text. In considering employer coercion, it is
important to note that “[e]ventually, without preventive legislative action, employers [may] begin to
demand that their employees accept neurological enhancement as a condition for employment or
promotion—and the working stiffs of the world will not have the financial power to resist.” Appel,
supra note 152, at 618. Two commentators have speculated on the possibilities of such a future:
It is not difficult to imagine that a worker’s willingness to use a drug that increased
productivity would soon become a factor in hiring and promotion. A company deciding
which law firm to engage might want to know which of them requires their attorneys to
use cognitive enhancers: the presumably higher efficiency would translate into fewer
hours billed and lower cost. Attorneys willing to use cognitive enhancers might earn
better fees and find more firms ready to hire them.
Whitehouse & Juengst, supra note 192, at 20. Employers already insist on some types of
enhancement; for instance, they may force their employees to take mandatory training programs or
risk losing their jobs. Greely, supra note 6, at 1150. However, this pressure does not consider other
ethical concerns involved with drug use—such as safety and fairness. See supra note 124 and
accompanying text.
198. Greely et al., supra note 9, at 703 (asking whether schools and employers “[s]hould be
allowed to require pharmaceutical enhancement”); see also Sahakian & Morein-Zamir, supra note
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These different social scenarios increasingly can emerge as medicinal brainboosting use becomes more widespread.199 Coercion—indirect or direct—
proscribes personal autonomy and lacks legitimate justification in the
educational setting.200 Instead of promoting a cognitive arms race among
students,201 educational policies may need to prohibit social pressures if the
ethical scales tilt towards these mandatory safeguards for the students’
greater good.202 To determine this ethical balance requires the analysis of
one final consideration—fairness.203

168, at 1159 (stressing the concern of direct and indirect coercion). For an in-depth study on school
administration coercion, see Marc Bousquet, Take Your Ritalin and Shut Up, 108 S. ATLANTA Q.
623, 625 (2009).
199. Fox, supra note 56, at 1148; see also Cakic, supra note 71, at 612 (explaining that a
sufficiently high portion of students must use cognitive enhancers before nonusers feel peer
pressured with the perception that “everybody else is taking them”). Studies already reveal that
brain-boosting drugs are prevalent on school campuses. See supra note 111 and accompanying text.
But, as one doping researcher explained, if drugs actually made people smarter, their use would turn
epidemic. Kaplan & Gellene, supra note 72. “‘Just think what it would do to anybody’s career in
about any area. There are not too many occupations where it’s really good to be dumb.’” Id.
200. See Greely et al., supra note 9, at 703 (“Employers, schools or governments should not
generally require the use of cognitive enhancements.”). Contra Cakic, supra note 71, at 613
(contending that restraining others’ actions to protect nonusers from feelings of coercion is equally
an attack on personal freedom). However, giving free reign to every cognitive-enhancer user
actually may allow individuals to identify their use as voluntary self-improvement, rather than
coerced consumption. Forlini & Racine, supra note 189, at 164; see also RICHARDS, supra note 2, at
172 (noting that treating everyone as equals means respecting the individual’s ability to choose).
Arguably, cognitive coercion may be appropriate when considering the safety of individuals that
others depend on in dangerous situations; for example, soldiers sometimes take stimulants to
increase alertness, but perhaps surgeons also should use safe brain boosters if the drugs would enable
them to save more lives. See Greely et al., supra note 9, at 703; see also Carol Lewis, Chemical
Allies to Boost Performance, TIMES (London), Oct. 14, 2004, at 10 (considering smart drugs for
doctors and pilots to facilitate sharper minds and faster reactions).
201. See Nick Bostrom & Rebecca Roache, Ethical Issues in Human Enhancement, in NEW
WAVES IN APPLIED ETHICS 120, 137 (Jesper Ryberg et al. eds., 2007).
202. See supra note 183 and accompanying text. However, one commentator warns, “[T]here is
something morally perverse in condemning drug use as intrinsic moral slavery when the very
prohibition of it seems to be an arbitrary abridgement of personal freedom.” RICHARDS, supra note
2, at 177.
203. See supra notes 124–25 and accompanying text. As one editorial stressed, “If you take away
the risk of personal harm, it becomes largely an argument of fairness.” Daniel Malherbe, Blogs Are
Abuzz About Brain Boosters, CAPE TIMES (S. Afr.), Mar. 11, 2008, at E1 (asking whether cognitiveenhancement medicinal use is cheating). Other ethicists suggest fairness is the predominant
consideration to determine the existence of cheating because the definition of “cheating” is mainly a
matter of fairness. Schermer, supra note 26, at 85; see also supra note 26.
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C. Mind Hacks: Fairness Concerns with Cognitive Advantages
Fairness encompasses a spectrum of ethical concerns from both
individual and societal perspectives.204 On the individual level, fairness
considerations largely focus on personal achievements and competition,205
while on the societal level, they primarily involve equal access and the
possibilities of increased discrimination.206
1. Personal Achievement
Critics of cognitive enhancement traditionally object to drug use as an
unnatural means to improve one’s mental abilities.207 This overlooks the
fact that while stimulants, narcolepsy medications, and beta blockers may
not be natural substances,208 other cognitive enhancers do occur in nature—
including caffeine, gingko, and nicotine.209 However, even naturally
occurring compounds may be used in an unnatural manner to artificially
boost cognition.210 In the classroom setting, this method of obtaining
scholastic achievement is a false self-improvement that differs from innate
talent or diligent study,211 partially because (1) it is more transitory in nature
204. Greely, supra note 6, at 1151–52.
205. See infra notes 207–48 and accompanying text.
206. See infra notes 249–80 and accompanying text.
207. See Mehlman, supra note 13, at 491 (noting that cognitive enhancers are singled out for
rebuke because they are not customary, traditional, or natural). In actuality, unnatural cognitive
enhancers may be traditional because of their long-lived existence:
Since Adam and Eve’s apple, however, the most controversial means of cognitive
enhancement have always been the enhancers we take rather than the ones we invent or
earn: the supernatural gifts, magic potions, or medical drugs that promise to expand our
abilities without requiring us to exert ourselves unduly in the process.
Whitehouse & Juengst, supra note 192, at 14; see, e.g., infra note 209 (noting the traditional use of
caffeine). In fact, proponents of cognitive enhancement call the “preferability of the natural” a status
quo bias that has long affected ethical analyses. Nick Bostrom & Toby Ord, The Reversal Test:
Eliminating Status Quo Bias in Applied Ethics, 116 ETHICS 656, 679 (2006).
208. See, e.g., supra note 92 (explaining that Provigil is a manufactured drug).
209. Mehlman, supra note 13, at 492 (specifically mentioning that caffeine has been used as a
natural brain booster for centuries); see also supra note 5 and accompanying text.
210. Greely, supra note 6, at 129. Some critics contend that this unnatural method of obtaining
academic accomplishments makes them both unearned and unworthy of reward. Mehlman, supra
note 13, at 492 (noting, however, that medicinal consumers are still likely to expend some effort to
produce praiseworthy results).
211. Katrina A. Bramstedt, Caffeine Use by Children: The Quest for Enhancement, 42
SUBSTANCE USE & MISUSE 1237, 1247 (2007). In finding the distinction between natural and
unnatural self-improvement, Bramstedt relies on the reasons behind the medicinal use:
The test for whether or not cognitive enhancement is cheating is the concurrent presence
or absence of a clinically diagnosed cognitive deficit. In the presence of such a deficit,
drug-mediated cognitive enhancement is not cheating but rather correction of a medical
problem. In the absence of such a deficit, drug-mediated cognitive enhancement is a
form of cheating because it circumvents the honest way of attaining excellence—that is,
diligent study.
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than the cognitive permanence gained by other natural means,212 and (2) it
diminishes the accomplishments of those who only use those other means.213
It also belies the consumer’s achievements by “confounding the
identity . . . acquired through natural gift cultivated by genuinely lived
experiences.”214 Studies demonstrate that mental characteristics like
intelligence are more fundamental to self-identity than physical attributes.215
Because people generally desire to express and preserve their own selfidentities,216 an unnatural enhancement of such a personal trait for the sake
of achieving better grades may engender personal antipathy rather than any
sense of actual accomplishment.217 In a correlating manner, enhancements

Id. at 1247–48. Bramstedt further points out that even if some students have more natural abilities
than others, unethical behavior is not the ethically appropriate means to fill gaps in natural talent. Id.
at 1248. This reasoning especially holds true for the unique ethically bound environments of
medical and law schools. See supra note 15 and accompanying text.
212. Whitehouse & Juengst, supra note 192, at 21. To actually increase the mind’s potential
requires the repeated use of the brain’s neural circuits; therefore, when a person focuses on or learns
a particular skill or subject, the mind’s capacity to process and retain data also improves as more
“neuronal real estate” is used. Begley, supra note 153, at 44.
213. Schieffelin, supra note 13, at 976–77.
214. Jason Riis et al., Preferences for Enhancement Pharmaceuticals: The Reluctance to Enhance
Fundamental Traits, 35 J. CONSUMER RES. 485, 497 (2008); see also Fox, supra note 56, at 1150
(“This objection has to do with the shift away from achievements humans undertake through selfinitiated striving, and toward those they experience by biochemical interventions, which act on us as
passive subjects.”). Life experiences, which take time and effort, have the potential to develop many
individual attributes—including emotions, strength, beauty, and intellectual endeavors. Torbjorn
Tannsj, Ought We to Enhance Our Cognitive Capacities?, 23 BIOETHICS 421, 428 (2009). For
example, while medicinal cognitive enhancement may enable a user to more easily learn a second
language, it also deprives such a consumer from the accomplishment of immersing oneself into a
foreign culture. Id. at 428–29 (“Generally speaking, making life easier is not tantamount to making
life better.”). Therefore, cognitive enhancers actually may violate the integrity of a person’s efforts
or endeavors. See Greely, supra note 6, at 1152.
215. Riis et al., supra note 214, at 497, 503; see also Whitehouse & Juengst, supra note 192, at
17 (noting that the human race’s “self defining feature and point of pride is that the form of sensation
we prize most is that which constitutes the life of the mind: cognitive experience”).
216. Riis et al., supra note 214, at 497. Nevertheless, some proponents of cognitive enhancement
contend that it is humanity’s “biologically grounded nature” to be open to artificial tools and
medications that literally become part of the consumer and create a new identity as the “soft self.”
Andy Clark, Re-Inventing Ourselves: The Plasticity of Embodiment, Sensing, and Mind, 32 J. MED.
& PHIL. 263, 278 (2007).
217. See Riis et al., supra note 214, at 497; see also Fox, supra note 56, at 1150 (explaining that
cognitive enhancers undermine the authenticity of self). This scenario may be more common with
cognitive enhancers that offer only a slight mental boost at the cost of reducing other human
capacities—such as creative thought, emotional depth, and perceptiveness. See Whitehouse &
Juengst, supra note 192, at 22; see also supra notes 154–55 and accompanying text. However, “[i]t
is possible that people who perceive themselves as worse than they ‘should be’ on some trait
dimension are more likely to enhance that trait in an effort to become ‘who they really are.’” Riis et
al., supra note 214, at 506. Other cognitive proponents additionally note that even if cognitive
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that require effort, such as meditation and brain games,218 are deemed more
socially and morally acceptable because they enable rather than artificially
enhance the self.219 Ultimately, the concern becomes whether obtaining
cognitive achievements through brain-boosting use “make[s] individuals less
themselves—less human and less them—in a way that deprives them of a
life lived genuinely and fully.”220
While considerations of personal achievement predominantly focus on
the subjective self,221 a fairness assessment also requires understanding how
potentially cheating the self can affect the accomplishments of others.222 A
consumer’s use of cognitive enhancers can be viewed in this larger
framework by questioning the effects of brain boosting in competitive
environments.223

enhancers negatively affect character, it would only be certain aspects of character. Maartje
Schermer, Enhancements, Easy Shortcuts, and the Richness of Human Activities, 22 BIOETHICS 355,
357 (2008) (“Virtues like justice, wisdom, humanity or transcendence appear to be less vulnerable to
the use of enhancers.”).
218. Begley, supra note 153, at 45.
219. See Riis et al., supra note 214, at 506; see also Whitehouse & Juengst, supra note 192, at 21
(“The traditional methods of expanding our capabilities, the pharmaceutical Calvinists argue, are
‘natural’ and therefore praiseworthy, while drug-induced abilities are ‘artificial’ and thereby
suspect.”). Contra Enhancing, Not Cheating, supra note 183, at 320. In opposition, the editorial
board of Nature contends that if medicinal enhancement can enable scientists or artists to achieve
new heights of performance, they are not suspect mechanisms. Id. Instead, “[f]ar from cheating on
themselves or others, they would be delivering a higher return on their investment of effort, and
indeed on society’s investment in them.” Id.
220. Fox, supra note 56, at 1151; see also supra notes 216–19 and accompanying text. Not all
ethicists view the utilization of brain boosters as a form of self-deprivation; instead, they argue the
opposite—that the banning of cognitive enhancers is an attack on personal autonomy that deprives
consumers of their human fulfillment:
Many other courses may reasonably and responsibly accommodate the diverse
individuality of human competences, aspirations, and ends. What for one is a reasonable,
self-imposed ideal of self-control and social service may be for another a self-defeating
impoverishment of human experience and imagination, a rigid and inflexible willfulness
without intelligent freedom or reasonable spontaneity, a masochistic denial of self and
subjectivity in the service of uncritical and dubiously manipulative moral aims.
RICHARDS, supra note 2, at 172 (arguing that moral conceptions are not valid justifications for
sanctioning or restricting drug use). But see supra notes 183, 202 and accompanying text.
221. See supra notes 211, 214 and accompanying text.
222. See, e.g., supra note 213 and accompanying text.
223. See supra note 205 and accompanying text. Competition, which can be defined as the
pursuit of victory or excellence, necessarily involves weighing or judging the accomplishments of all
competitors to determine the winners. See Sarah J. Wild, On Equal Footing: Does Accommodating
Athletes with Disabilities Destroy the Competitive Playing Field or Level It?, 37 PEPP. L. REV. 1347,
1353 (2010); see also supra note 222 and accompanying text (noting the need to consider others’
achievements in a fairness analysis).
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2. Competitive Endeavor
Any analysis that considers the fairness implications of medicinal
enhancement in competitive situations should begin with a look at the
clearest example of competitive activity—sports.224 In the athletic arena,
drug use is not only viewed as taboo, it also is seen as fundamentally
incompatible with sports225 because society values winners for their
natural226 rather than artificial efforts.227 Illegal drug use also violates the
actual rules of sport.228 Most notably, WADA already prohibits all four
types of cognitive enhancers in different athletic competitions.229 When
deciding whether to ban a substance from international athletics, WADA

224. See Savulescu, supra note 71, at 326. Athletics offers a fitting starting point for most
fairness evaluations because the “paradigmatic example of cheating as gaining an unfair advantage
over others by breaking the rules comes from competitive sports.” Schermer, supra note 26, at 85.
225. Mehlman, supra note 13, at 490; see, e.g., supra notes 106–07 and accompanying text. For
instance, Kelli White, an American sprinter who won two gold medals at the 2003 World Track
Championships, lost her medals and received a two-year suspension after testing positive for
Provigil. Greely, supra note 49, at 126–27. Although her family exhibited a history of narcolepsy
and she had a valid prescription, White admitted to taking the drug for competitive rather than health
reasons. Wild, supra note 223, at 1379 n.142. Even before her confession, the International
Association for Athletics Federations was contemplating punishment merely because her case
involved drug use during competition. See Greely, supra note 49, at 127.
226. Natural efforts encompass determination, talent, and luck. Mehlman, supra note 13, at 490.
Some proponents of performance enhancement point out that victory in competition is significantly
dependent on the “genetic lottery.” W. Miller Brown, The Case for Perfection, 36 J. PHIL. SPORT
127, 128 (2009). They contend, “No matter the extent of our effort and courage in the pursuit of
athletic excellence, most of us do not have the genetic endowments to succeed at world-class
competition.” Id. While this genetic discrepancy probably is unfair, more importantly from an
ethical view, natural efforts are morally neutral—neither just nor unjust. Id.
227. Mehlman, supra note 13, at 490; see also supra notes 210–11 and accompanying text.
Society upholds natural efforts as the means to make victories both deserved and authentic;
conversely, the general public views drug use as the tool that creates undeserved and inauthentic
accomplishments. See Mehlman, supra note 13, at 490, 493. Therefore, true competition is the
“quest for excellence through challenge,” and the question becomes whether medicinal performanceenhancement use essentially destroys such a challenge. Wild, supra note 223, at 1354–55, 1362
(mentioning that some view drug use as an easy way to win). For a more in-depth analysis of the
“easy win” or shortcut contention, see Schermer, supra note 217, at 360–63.
228. Mehlman, supra note 13, at 490; see also Savulescu, supra note 71, at 327 (noting that
“[c]onsiderations of fairness play a prominent part in the regulation of drugs in sport”). For an
examination on the standardized rules governing athletic competitions, see Wild, supra note 223, at
1356–58 (describing how these regulations attempt to create fair results that reflect the competitors’
pursuits of excellence).
229. See supra note 130 and accompanying text; see also Wild, supra note 223, at 1359–60
(explaining that the regulation of performance enhancers primarily focuses on substances rather than
other artificial tools). To enforce these prohibitions, the International Olympic Committee drug tests
or “dope checks” athletes at all major games and contests. Schermer, supra note 26, at 85; see, e.g.,
supra note 225.
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considers whether the drug would (1) potentially enhance sport performance,
or (2) violate the spirit of sport.230 Therefore, WADA prohibits cognitive
enhancers because it recognizes that they can give athletes an unfair
advantage or violate the fundamental spirit of competition, or both.231 If
athletes break these explicit rules to gain an enhancing edge, they
unequivocally cheat the game.232 Essentially, performance-enhancing drugs
jeopardize the integrity of sports and transform their athletic users into
“cheaters” when they “eliminate athletic talent as a prerequisite for
competition.”233
Similar to athletics, medical and law schools are also competitive
environments234 where students continuously compete for the handful of top
positions in their class ranks so they can earn academic gold medals—such
as Dean’s recognitions, clinical and journal positions, graduation honors,
and employment opportunities.235 In this competitive setting, students “are
often driven by the rewards and permitted by the low penalties to seek unfair
advantage[s]”236—specifically through brain-boosting medications.237
However, unlike the sports world, medical and legal academia does not have
230. Savulescu, supra note 71, at 327. WADA actually defines the “spirit of sport” as ethics, fair
play, honesty, respect for rules and laws, and respect for the self and other participants. Id.
231. Id. But see supra note 130 and accompanying text. For instance, Greely explained that
significant fairness concerns arise when some athletic competitors use enhancing drugs, while others
do not. Greely, supra note 6, at 1151.
232. See Schermer, supra note 26, at 85. For the definition of cheating, see supra note 26.
233. Wild, supra note 223, at 1359.
234. McGuire & Phye, supra note 15, at 63. It is important to establish medical and law school
educations as uniquely competitive activities to differentiate these settings from other graduate or
lower education programs. See supra note 13 and accompanying text. Of course, although this
outlook is realistic and accurate, it undercuts the ideological view of higher education:
Education and studying have internal goods next to their more instrumental goals. Such
internal goods may be the attained appreciation of the internal goods of the practices one
is educated in, knowledge and truth, the activity of studying with its character-building
side effects, or the general (moral) self-development it effectuates. . . . [T]hese are the
ends of education, but these are increasingly substituted by a rat-race in which only
exams and test-results count.
Schermer, supra note 26, at 88 (contending that cognitive enhancers cannot add to the ultimate ends
of education). For instance, while brain boosters may temporarily improve memory or attention,
they still undermine active learning, disciplined study, and creative insight. Id.; see also supra notes
154–55 and accompanying text.
235. See supra notes 190–91 and accompanying text. Because this type of competition involves
limited prizes, it engenders an “inherently selfish venture” that essentially transforms medical and
law schools into zero-sum settings. See Wild, supra note 223, at 1353; see also supra note 12
(noting that Greely argued for the acceptance of medicinal cognitive enhancement in non-zero sum
school environments).
236. See Savulescu, supra note 71, at 328; see also supra note 194.
237. See, e.g., supra notes 71, 80, 111 and accompanying text. Brain boosters are inherently
unfair and facilitate deceptive behavior in an examination setting because an exam performance is
supposed to represent the “accumulation of a semester’s worth of work” and the student’s own
efforts, not the student’s “chemically induced performance.” Fenton & Wunderlich, supra note 44,
at 18.
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an oversight body like WADA that explicitly forbids legally prescribed
medications in a classroom setting.238 Instead, these schools establish honor
codes that implicitly govern different forms of scholastic conduct.239 When
applicants become students and take up the mantels of the medical or legal
profession, they are tacitly accepting these rules and their professional
associations’ corresponding ethical guidelines as valid restrictions on their
actions.240 When they break these rules to create unfair advantages against
their studious peers, they become academic cheaters against themselves241
and others.242 This holds especially true in a competition analysis because
medical and law school examinations243 are the epitome of zero-sum
activities.244

238. See supra note 219 and accompanying text; see also Schermer, supra note 26, at 87 (noting
that the rules of the educational game are not as clear or explicit as sports regulations).
239. See supra notes 22–23 and accompanying text. Nevertheless, honor codes or exam
regulations are not overt rules against medicinal cognitive enhancement because they do not
expressly forbid such drug use before exams or during study. Schermer, supra note 26, at 87.
240. See Schermer, supra note 26, at 85; see also supra notes 17–24 and accompanying text.
241. See supra notes 211–14 and accompanying text. If exams are meant to test a student’s
personal performance and signify his or her individual achievement, the use of a cognitive enhancer
to acquire a certain grade would be akin to allowing the use of a calculator on a math test or roller
skates in a marathon. Schermer, supra note 26, at 87 (asking whether the brain booster would
undercut the rationale behind an exam); see also supra note 14 and accompanying text.
242. See Schermer, supra note 26, at 85; see also supra note 231 and accompanying text. For
example, if a student takes Adderall to obtain better grades than his or her academic peers and such a
“study tool” is against school rules, the student is cheating. Savulescu, supra note 71, at 327. Here,
cheating essentially means earning prized grades through artificial tools, rather than on actual merit.
See Schermer, supra note 26, at 86. GPA rankings are only fair if schools distribute them to students
because they are earned or deserved through natural abilities or studious training. See id. In the
most basic sense, justice and fairness dictate that the top ten to fifteen percent of each class actually
merit their rankings. See id. at 87.
243. Respective universities usually require professors to grade medical and law school exams on
predefined tight curves, where sometimes less than fifteen percent of the class even has a chance at
earning an A-level grade. See, e.g., George Kulick & Ronald Wright, The Impact of Grading on a
Curve: A Simulation Analysis, INT’L J. SCHOLARSHIP TEACHING & LEARNING, July 2008, at 1, 3–4,
available at http://academics.georgiasouthern.edu/ijsotl/v2n2/articles/PDFs/Article_Kulick_Wright.pdf
(discussing grade curves in pre-med and medical programs); Law School Grading Curves,
Memorandum by Andy Mroch, from Ass’n of Am. Law Schs., (Mar. 30, 2005), available at
http://www.aals.org/deansmemos/Attachment05-14.pdf (analyzing grade curves from a swath of
legal universities). This type of grading creates the zero-sum setting. See supra note 235 and
accompanying text. When medicinal cognitive enhancement enters this grading calculation,
professors must try to compare “apples and oranges”—students with the added medicinal edge, and
those taking examinations under normal conditions. Fenton & Wunderlich, supra note 44, at 20.
244. See Fox, supra note 56, at 1147 (“[E]nhancements generate unfairness when individuals use
them to gain relative advantage over others in zero-sum competitions such as athletic events and
academic testing.”); Goodman, supra note 81, at 149; see also supra notes 234, 242 and
accompanying text. Zero-sum activities or environments always require the existence of a winner
and a loser. Goodman, supra note 81, at 149. This zero-sum delineation may explain why
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Although medicinal cognitive enhancement clearly creates unfair
scholastic advantages in medical and law schools,245 it may not be a form of
academic cheating if no specific regulatory framework actually forbids such
enhancement.246 After all, cheating fundamentally requires the violation of a
rule to obtain that unfair edge.247 If the unfair advantages themselves
disappear because all students acquire equal access to the enhancement, then
the fairness equation changes even more dramatically—perhaps even
necessitating a new calculation.248
3. Equal Access
Cognitive enhancers are positional goods249 because they give users
advantages over others when competing for academic grades and honors.250
Unfairness thus arises when only a select few have the ability to purchase or
consume these goods.251 This necessarily raises social-equity concerns252
numerous commentators analogize athletic performance-enhancement drug use with academic
cognitive-enhancement drug use. See, e.g., Bostrom & Roache, supra note 201, at 137 (“Just as
using drugs to enhance one’s strength is seen as cheating in professional sport, using drugs to
improve one’s memory in order to perform better in an examination could be seen as cheating.”);
Schermer, supra note 26, at 87 (noting that the parallel with sports offers insights into educational
cheating arguments).
245. See supra notes 241–42 and accompanying text.
246. See supra note 239 and accompanying text. “So, as long as schools or universities, or other
supervising authorities do not issue rules against the use of modafinil, Ritalin or any other cognitive
enhancer, students can use whatever they want without it being cheating.” Schermer, supra note 26,
at 87 (noting, however, that “[t]here may be some inarticulate rule broken by the use of cognitive
enhancers, which would make their use a form of cheating”).
247. See supra note 26 and accompanying text; see also Greely, supra note 6, at 1152 (explaining
that cheating unequivocally happens when a person does not follow a rule that actually is enforced).
Merely obtaining an unfair advantage without breaking the rules is not necessarily cheating.
R. MERKEL ET AL., INTERVENING IN THE BRAIN: CHANGING PSYCHE AND SOCIETY 353 (Carl
Friedrich Gethmann ed., 2007). For example, genetic disposition and innate natural intelligence
foster discrepant advantages that society admires and encourages. See id. (“What then exactly
explains the difference if we substitute ‘artificial medical enhancement’ for ‘genetic giftedness’?”);
see also supra note 226 and accompanying text.
248. See Schermer, supra note 26, at 86.
249. Positional goods are tangibles or intangibles that “confer substantial advantages on their
possessors relative to others within the context of social competition for scarce and valued positions
and other desired goods.” MERKEL ET AL., supra note 247, at 359.
250. Bostrom & Roache, supra note 201, at 137; see also supra text accompanying note 245.
251. Mehlman, supra note 13, at 488; see also Fox, supra note 56, at 1147 (“[L]imited access to
enhancement biotechnologies exacerbates inequalities of wealth and status between the haves and
the have-nots.”).
252. Purchasable positional goods generate social-equity concerns because their limited
availability can create a spiraling effect that interferes with the idea of equitable distribution:
If (1) means of mental enhancements are available only to the wealthy and (2) making
use of such means confers substantial competitive advantages for the acquisition of
additional advantages, including wealth, and (3) a grossly unequal distribution of wealth
is a matter of concern for distributive justice, then the exacerbating effect of artificial
mental enhancements on problematic patterns of social distribution is obvious.
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that stem from the public’s desire to establish equality “between individuals
and across society.”253 However, such concerns may be alleviated if
everyone has equal access to these positional goods.254 Presently, the use of
cognitive enhancers is limited by income,255 chance, and geography.256 In
light of such limitations, proponents of medicinal enhancement suggest that
health insurance companies, the government, or even private philanthropies
could provide cognitive enhancers to those without sufficient means.257 The
President’s Committee on Bioethics also added (perhaps sarcastically) that
free cognitive enhancers could be supplied “at the door as students file into
the testing room, so that all who wished to take [them] could do so, and we

MERKEL ET AL., supra note 247, at 359.
253. Greely, supra note 6, at 1151–52 (noting, for example, that society already provides
equitable access to education for all children across class and racial lines). However, society does
tolerate certain sources of inequality, including the advantages obtained by wealth, natural talent,
good luck, and powerful social connections. Mehlman, supra note 13, at 490. Nevertheless, society
may decline to accept the inequalities fostered by medicinal cognitive enhancement because
“cognitive enhancement could be so powerful a determinant of social success that it would
undermine the foundations of our liberal, democratic society.” Id.; see also supra note 251 and
accompanying text.
254. Savulescu, supra note 71, at 332–33. This “would make everyone more equal, creating a
society in which there was greater equality of opportunity.” Mehlman, supra note 13, at 498.
255. See, e.g., supra note 148 and accompanying text (explaining the significant difference in the
prices for beta blockers and Provigil). Because cognitive enhancers are relatively expensive, they
can potentially create a “modern caste system” that will favor the wealthy. MERKEL ET AL., supra
note 247, at 43.
256. See Greely, supra note 49, at 129. Furthermore, the DEA places manufacturing restrictions
on Adderall, Ritalin, and Provigil because they are controlled substances. See Mehlman, supra note
13, at 488; see also supra note 120 and accompanying text. This limits their overall supply and
national availability. Mehlman, supra note 13, at 488. However, even if they existed in an
unlimited supply, the FDA still requires valid physician prescriptions for all four types of cognitive
enhancers. See id.; see also supra note 118 and accompanying text. A prescription requirement
mandates access to a personal physician—creating yet another cost-prohibitive hurdle. See
Mehlman, supra note 13, at 488, 490 (noting, for instance, that more than 40 million Americans lack
health-insurance coverage). But see supra note 121 (describing online purchasing without needing a
prescription).
257. See MERKEL ET AL., supra note 247, at 358 (discussing the possibility of health-care
coverage); Mehlman, supra note 13, at 489, 498–500 (promoting subsidy programs). However, if
these entities provide medications that consumers will use for mere enhancement purposes, they
potentially could be wasting the available supply of medical resources. See MERKEL ET AL., supra
note 247, at 362–63 (explaining the “resource-squandering” effect). This essentially means:
[T]hat medical means, including expert manpower, used up for one particular purpose are
necessarily unavailable for any other potential application. If they are used for
enhancement purposes, the resources thus deployed are not available for use in the much
more important area of treatment, where they function as potentially life-saving or healthrestoring means.
Id. at 363. Besides the waste of medicinal resources, some may argue that these public and private
entities are misusing their own funds that could be utilized to help the truly unhealthy. See id.
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would know it was being properly administered.”258 Securing equitable
access may “potentially increase equality in society by enabling those with
lower cognitive ability to function at a level that is closer to those with
naturally high cognitive ability.”259 However, if cognitive enhancers do
become available to everyone, questions of social coercion260 would again
emerge—would individuals who deliberately refuse to take these drugs be
disadvantaged given that others’ cognitive levels were artificially raised as
standard procedure?261 Moreover, equal access may not be the end-all
solution when considering the entire ethical status of enhancement.262 In
fact, it actually may facilitate the final societal concern by increasing
discrimination.263
4. Increased Discrimination
While equal access to cognitive enhancers initially appears to “make
everyone more equal [by] creating a society in which there [is] greater
equality of opportunity,” this oversimplifies the approach.264 Instead,
consider the ramifications of equal access on a standard population
characterized by intellectual differences:

258. Lerner, supra note 42, at 1071 (noting that this suggestion has its own drawbacks).
259. Bostrom & Roache, supra note 201, at 138. Equal access levels the mental playing field.
See MICHAEL S. GAZZANIGA, THE ETHICAL BRAIN: THE SCIENCE OF OUR MORAL DILEMMAS 70
(2005). But see infra notes 265–69 and accompanying text. Two proponents recently suggested that
such mental equality also will level economic disparities: “[I]t has been estimated that a 3 per cent
population-wide increase in IQ could reduce poverty rates by up to 25 per cent and increase GDP by
up to 1.5 per cent.” Barbara J. Sahakian & Ahmed D. Mohamed, Going Mental, PROSPECT, June
2010, at 68, 68. Basically, they propose that equal access to cognitive enhancers will eventually
mitigate societal poverty. Id.
260. See supra notes 193–98 and accompanying text.
261. See MERKEL ET AL., supra note 247, at 43; see also supra notes 194–95 and accompanying
text. If cognitive-enhancement drug use became a “social practice undertaken by large numbers of
people,” the “aggregate will of others” will exert pressure on the drug free. MERKEL ET AL., supra
note 247, at 364.
262. Michael J. Sandel, The Case Against Perfection: What’s Wrong with Designer Children,
Bionic Athletes, and Genetic Engineering, ATLANTIC MONTHLY, Apr. 2004, at 50, 52 (“[T]he
fundamental question is not how to ensure equal access to enhancement but whether we should
aspire to it in the first place.”).
263. Whitehouse & Juengst, supra note 192, at 19; see also supra note 206 and accompanying
text. For example, equal access potentially fosters discrimination against the naturally fortunate by
equalizing the mental playing field. Whitehouse & Juengst, supra note 192, at 19. Contra
Savulescu, supra note 71, at 335. In this sense, discrimination means a person is guilty or unethical
when his actions penalize another simply because that other person is a member of a certain group.
See Lerner, supra note 42, at 1049.
264. Mehlman, supra note 13, at 498. In actuality, equal access can potentially “reshape the
[mental] playing field in unanticipated ways—just as the use of calculators works to the relative
disadvantage of students who are quickest at doing long division with pencil and paper.” Goodman,
supra note 81, at 150.
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[S]uppose cognitive enhancements gave people a certain boost in
their cognitive ability—say made them 20 percent smarter.
Suppose further that cognitive enhancements were given to all those
in the lower half of the “normal” range. These individuals, along
with those with below-normal cognitive ability who received the
interventions therapeutically, would move up 20 percentage points.
But people in the upper half of the population range who obtained
enhancements on their own would move up as well. The entire
population would move upward in terms of cognitive ability, but the
disparities created by natural talent and luck would remain.265
Nonetheless, cognitive enhancers do not affect everyone equally;266 they do
not raise everyone’s cognitive ability to the same mental ceiling.267 While
some drug users may achieve a fifty percent mental improvement, others
may only see a five percent increase.268 Similarly, consumers who attain
small intellectual gains can still accomplish significant scholastic outcomes
through other abilities.269 Therefore, cognitive enhancers may only add to
the list of undeserved factors270 that generate individual success and increase
societal differences.271
Furthermore, cognitive-enhancement drug use by the healthy “usurps
the accommodation provided to those with real disability, thus denying them

265. Mehlman, supra note 13, at 498–99. This hypothetical demonstrates how equal access fails
to remove natural discrepancies in intellectual abilities, especially if naturally smart people also take
brain boosters—meaning people who function at lower levels will never have the opportunity to
catch up. See id.; see also supra note 253. But both the equal access and personal autonomy
concerns suggest that medicinal cognitive enhancement cannot and should not be limited to those
below a certain intellectual level. See supra notes 183, 251 and accompanying text. However, this
scenario also assumes that cognitive enhancers boost everyone’s mental capacity in the same
incremental amount. See Mehlman, supra note 13, at 498. Contra infra notes 266–67 and
accompanying text.
266. Begley, supra note 153, at 43. For example, because Adderall and Ritalin work by raising
dopamine levels in the brain, they provide less benefit to individuals with naturally high dopamine
activity. Id. In fact, some people can achieve the same dopamine-boosting benefits by simply
believing in their own success—which also increases dopamine. Id.
267. Mehlman, supra note 13, at 499.
268. See id.
269. See Sahakian & Mohamed, supra note 259, at 68 (“[A] 10 per cent improvement in memory
score could [still] lead to a higher A-level grade or degree classification.”).
270. See supra notes 227, 253 and accompanying text. In a university setting, good school
performances are partly determined by unearned factors, such as inborn ability and luck, but they
also require effort and determination. Schermer, supra note 26, at 87 (explaining that praise is given
for the effort and endurance that is put into the performance, and not just for the final outcome).
271. Mehlman, supra note 13, at 499.
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their equal playing field.”272 All four types of cognitive enhancers are
medications that doctors prescribe for FDA-approved treatments.273
Students who take cognitive enhancers for learning disabilities like
AD/HD274 are disadvantaged when the healthy consume the same
medications for purely enhancement purposes.275 However, some of these
students may have actively pursued a learning disability diagnosis merely to
obtain their own prescription enhancers.276
To understand the ethical difficulties arising from these different
scenarios, imagine that intelligence is ranked on a scale from 1 to 10.277 A
performs at Level 8, B performs at Level 5, and C performs at Level 2. At
Level 2, C obtains a prescription for Adderall based on a validly diagnosed
learning disability, but this drug enables C to perform at Level 7. Is this fair
to B, especially in a zero-sum scholastic setting?278 Perhaps B should now
take cognitive enhancers because he is mentally below both A and C.
Assume B does “game the system” and with the help of Ritalin now
performs at Level 9. A discovers the cognitive use and secures her own
brain boosters, which may or may not increase her cognitive abilities. Either
way, C—who had the valid disability—is still denied equal footing on the
intelligence scale. Such a hypothetical illustrates the inherent unfairness of
improper cognitive-enhancer use279 and has led numerous critics to contend
272. Fenton & Wunderlich, supra note 44, at 18. “Proper use [of cognitive enhancers] is like a
person with poor vision wearing glasses so they can see the ball as clearly as those who naturally
have 20/20 vision. Improper use is more akin to a nonhandicapped person parking in handicapped
spaces.” Id. Proper use occurs when an intellectually disabled individual takes cognitive enhancers
for the chance to lead a good life. Savulescu, supra note 71, at 334. Low intelligence is a disease
when the IQ is less than 70, and doctors already use pharmacological means to treat this disease. Id.
273. See supra notes 128, 256 and accompanying text.
274. A learning disability is an “unexplained learning discrepancy—academic underachievement
that cannot be explained by an observable physical or mental handicap.” Lerner, supra note 42, at
1059–60, 1065; see, e.g., supra note 272.
275. See Greely, supra note 6, at 1153 (noting that in a society of enhanced individuals,
discrimination may increase against those—such as the disabled or sick—who cannot achieve this
same mental enhancement); see, e.g., supra note 42 and accompanying text; see also MERKEL ET
AL., supra note 247, at 388 (explaining the difference between enhancement and valid treatment).
Essentially, if everyone is “focused on becoming Supermen and Superwomen, the people who are
left behind will be left even further behind.” Greely, supra note 6, at 1153.
276. See Lerner, supra note 42, at 1075 (additionally discussing how “an LD diagnosis can mean
shortened homework assignments, additional and personalized assistance, exemptions from
otherwise required classes, and accommodations on exams”); see also Freedley Hunsicker, Learning
Disabilities, Law Schools and the Lowering of the Bar, 42 S. TEX. L. REV. 1, 4–5, 13–17 (2000)
(analyzing the fairness of learning-disability accommodations in law schools). Of course, if other
students suspect that their peers are “gaming the system,” they may (1) socially stigmatize the
cognitive-enhancer users, (2) report them to administration, or (3) follow their examples. See
Lerner, supra note 42, at 1075; see also supra notes 23, 194 and accompanying text.
277. The author created the following hypothetical to illustrate the fairness implications involved
infra at notes 278–80 and accompanying text.
278. See supra notes 243–44 and accompanying text.
279. Fenton & Wunderlich, supra note 44, at 18.
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that natural efforts free of drug use are the more acceptable means of
securing academic achievements because they are morally neutral.280
While safety concerns, social implications, and fairness issues are the
three main concerns that proponents and critics repeatedly address when
debating the morality of cognitive-enhancement use by society at large,281
these categories take on new meaning and generate even more ethical
dilemmas when analyzed within the narrower setting of medical and law
schools.282 For example, the zero-sum characteristic of most medical and
law school examinations dictates that most artificially-obtained unfair
advantages are forms of scholastic cheating.283 Fundamental to this ethical
analysis is the reality that medical and law school students must study and
work within ethics-based guidelines and rules.284 Therefore, after fully
weighing all three ethical concerns,285 it becomes clear that the scales tip
away from personal autonomy and towards mandatory safeguards in these
higher education settings.286 This means that university administrators and
professional associations should both recognize and monitor medical and
law school students’ medicinal cognitive-enhancement use if they wish to
prevent cognitive cheating and uphold the values embraced by their
respective professions.287
IV. SMART POLICY: SUGGESTIONS TO PREVENT COGNITIVE CHEATING
Greely and Sahakian—well-known proponents of medicinal
enhancement288—have both cautioned that in a scholastic environment,
educators and professional organizations should implement regulations when
Such
cognitive-enhancement drug use imparts unfair advantages.289

280. See supra note 226 and accompanying text. Specifically, one commentator suggests that
cognitive enhancers disrupt the ideal of fairly earned praise in academia: “[T]o what extent can you
take credit for accomplishments if they are not achieved through the socially valued practices, like
study and effort that have traditionally produced them?” Schermer, supra note 26, at 87.
281. See supra note 124 and accompanying text.
282. See, e.g., supra notes 189–92, 216–17, 235–37 and accompanying text.
283. See supra notes 241–44 and accompanying text.
284. See supra notes 239–42 and accompanying text.
285. See supra notes 126–280 and accompanying text.
286. See supra notes 186–87 and accompanying text.
287. See supra notes 15–16, 188 and accompanying text.
288. See supra notes 8–9 and accompanying text.
289. See Greely et al., supra note 9, at 704–05; Sahakian & Morein-Zamir, supra note 168, at
1159. For well-written analyses explaining why the government and Congress cannot create and
enforce these laws or regulations that prohibit cognition-improving products, see RICHARDS, supra
note 2, at 185–88, and Mehlman, supra note 13, at 495–97.
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regulations are particularly needed in medical and law schools where
students’ medicinal brain boosting gives them an academic edge against
their studious, but drug-free, peers.290
A. The Drug War: Recruitment of University Administrators
Because cheating involves obtaining an unfair advantage,291 ethicists
suggest that universities could implement two different procedures to
eliminate medicinal cognitive advantages:
Academic institutions could follow the model of sports leagues and
explicitly ban enhancers for students enrolled in competitive
courses or taking competitive exams; they could even institute
random drug testing. At the other extreme, they could follow the
lead of ethicists like Allen Buchanan, who compare the use of
CEDs [cognitive enhancement drugs] to the use of calculators on
math exams. On that reasoning, professors might make cognitive
enhancement an explicit course expectation and even distribute
CEDs before exams, or professors might permit CEDs without
distributing them.292
Both these approaches focus on obtaining fairness through consistent, clear,
and enforceable rules.293 However, the ethical concerns stemming from
cognitive-enhancement drug use encompass more than fairness inquiries.294
When safety and societal implications enter the cheating equation,295 the
equal access approach is no longer a valid consideration.296 Instead,
suggestions for university monitoring must focus on methods that ban or
discourage medicinal brain boosting as an ethical violation.297
Traditionally, educational institutions have dealt with impermissible
drug use in three ways—drug testing, transcript asterisking, and early
preventative action.298 While these methods also may work to prevent
medicinal cognitive enhancement, universities must first establish rules that

290. See supra notes 241–44 and accompanying text.
291. See supra note 26 and accompanying text.
292. Goodman, supra note 81, at 150 (citations omitted); see also supra notes 238, 258 and
accompanying text.
293. Goodman, supra note 81, at 150.
294. See supra note 124 and accompanying text.
295. See supra notes 124–25 and accompanying text.
296. See supra notes 260–63, 292 and accompanying text.
297. See supra notes 287, 292 and accompanying text; see also Fenton & Wunderlich, supra note
44, at 18 (noting that medicinal cognitive enhancement is an unethical and deceptive practice that
undermines the integrity of education).
298. See Fenton & Wunderlich, supra note 44, at 20–21.
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clearly prohibit this type of drug consumption.299 The government already
recognizes that cognitive-enhancer use is illegal without a physician’s
prescription.300 In upholding these laws, both medical and law school
student handbooks include rules that forbid illicit drug use.301 Some
universities also penalize and discourage the abuse of legally obtained
drugs.302 However, medical and law schools still need to establish policies303
that explicitly ban illegally304 and legally obtained prescription medications
when used purely for cognitive-enhancement purposes before medicinal
brain boosting officially becomes a recognized form of scholastic
cheating.305 Clear, consistent rules allow university administrators to

299. See Goodman, supra note 81, at 150.
300. See supra notes 119–21 and accompanying text.
301. See, e.g., EMORY UNIV. SCH. OF MED., MEDICAL STUDENT HANDBOOK 65–66 (2010),
available at http://www.med.emory.edu/education/omesa/SOM_Handbook_2010_2011.pdf; HARVARD
LAW SCH., HANDBOOK OF ACADEMIC POLICIES 99–100 (2011), available at
http://www.law.harvard.edu/academics/handbook/2011-12handbookofacademicpolicies.pdf; MERCER
UNIV. SCH. OF MED., MEDICAL STUDENT HANDBOOK 74 (2011), available at
http://medapps.mercer.edu/index.php?header=off&file_path=/mednet/handbooks/&file_name=stude
nthandbook.pdf; SUFFOLK UNIV., GRADUATE STUDENT HANDBOOK 95–101 (2010), available at
http://www.suffolk.edu/files/Student_Services_PDF/Grad_Student_Handbook_2010_092910.pdf;
WASH. & LEE UNIV., STUDENT HANDBOOK 33 (2011), available at http://law.wlu.edu/
deptimages/student%20services/StudentHandbook.pdf.
302. See, e.g., BIRMINGHAM SCH. OF LAW, STUDENT HANDBOOK 35–36 (2009), available at
http://www.bsol.com/BSL_Handbook09.pdf (warning that “[a]ny student who presents themselves
for class in an impaired state (including over medicating with prescription drugs) is subject to being
dismissed from class by their professor and subject to possible dismissal from BSL” and that any
“student suspected of substance abuse or dependency (prescription or non-prescription drugs) may
be required to undergo testing and/or treatment as a condition of . . . continued attendance”); DUKE
SCH. OF NURSING, STUDENT HANDBOOK 38 (2010), available at http://nursing.duke.edu/sites/
default/files/current_students/phd_student_handbook_2011-20121.pdf (cautioning that “misuse of
legal drugs” that can result in “health difficulties impairing performance” may warrant withdrawal
from the nursing program if it poses a danger to patients or other students); GEORGE WASHINGTON
SCH. OF MED., STUDENT HANDBOOK FOR HEALTH SCIENCES PROGRAMS 16 (2011), available at
http://www.gwumc.edu/healthsci/academics/Health_Sciences_Student_Handbook.pdf (explaining
that inappropriate student behavior includes “using illegal drugs or abusing controlled substances”).
303. I emphasize “still” because higher educational institutions typically are reluctant to address
medicinal cognitive enhancement. See Appel, supra note 152, at 616. For example, “[f]or all
particular purposes—except within the limited realm of state-run schools—neurocognitive
enhancement remains no more regulated today than any other basic medical or pharmacological
interventions.” Id.
304. Although university drug policies already ban illicit drug use, prohibitions must explicitly
focus on medicinal cognitive enhancement as a separate form of academic cheating. See supra note
301 and accompanying text.
305. See supra notes 246–47 and accompanying text. One commentator aptly explained the need
for unambiguous rules:
When new enhancement technologies are introduced . . . the question of cheating cannot
be answered with a simple appeal to existing rules. The question is whether the old rules
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enforce the prohibition on such cheating through the common methods
employed against any other forbidden drug use.306
1. Drug Testing
Drug testing is the most common traditional tool employed to deter
prohibited drug abuse in many sectors of society.307 For example, the United
States Department of Defense began drug testing military personnel as early
as the 1960s.308 Drug testing has since expanded to the athletic,309
employment,310 and educational arenas.311 When applying drug-testing

still suffice to deal with the new technological possibilities. If the new technology offers
some unfair advantage, it may have to be banned by new rules.
Schermer, supra note 26, at 85–86; see also infra note 306 and accompanying text. In the law
school setting, if administrators unequivocally recognize medicinal cognitive enhancement as a form
of cheating, then law schools and individual professors can report this questionable behavior to state
bar authorities when they consider certifying applicants who incurred this academic violation.
McCulley, supra note 19, at 856.
306. See supra notes 298–99 and accompanying text.
307. See Stephen O. Griffin et al., Developing a Drug Testing Policy at a Public University:
Participant Perspectives, 30 PUB. PERSONNEL MGMT. 467, 468 (2001); see also infra notes 308–11
and accompanying text.
308. Griffin et al., supra note 307, at 468.
309. Pavisian, supra note 42, at 194–96. Both WADA and the National Collegiate Athletic
Association (NCAA) administer random drug tests on qualifying athletes. Id.; see also supra note
229 and accompanying text. The NCAA is a private entity that helps U.S. universities regulate their
student athletic programs. Pavisian, supra note 42, at 194. Under the NCAA scheme, when a
student athlete tests positive for a banned substance, the NCAA suspends that athlete until he or she
tests negative on a subsequent drug test. Id. The United States Anti-Doping Agency administers
drug tests for WADA on any foreign athlete present within the United States and on any athlete who
participates in a competition sanctioned by the United States Olympic Committee. Id. at 195–96.
Both athletic organizations give athletes therapeutic use exemptions when they consume prohibited
drugs for authorized medical purposes. Id. (explaining that the athlete has the burden of requesting
such an exemption from his or her respective anti-doping agency).
310. Griffin et al., supra note 307, at 467–68. Private companies began to increasingly drug test
employees and applicants in the early 1980s, but the Anti-Drug Abuse Act of 1986 really spurred
drug-testing growth in both the private and public sectors. Id. at 468; see also Anti-Drug Abuse Act
of 1986, Pub. L. No. 99-570, 100 Stat. 3207. In the public arena, the Omnibus Transportation
Employee Testing Act of 1991 (implemented in 1994 and amended in 2010) mandated drug and
alcohol testing for all “employees in safety-sensitive positions in the railroad, airline, mass transit,
motor carrier, and pipeline industries.” Griffin et al., supra note 307, at 468; see also Omnibus
Transportation Employee Testing Act of 1991, Pub. L. No. 102-143, 105 Stat. 917. Currently, the
federal government applies random drug testing to all its employees in safety-sensitive positions.
Griffin et al., supra note 307, at 468. In the private arena, drug-testing policies also remain on the
rise; for example, from 1987 to 1996, drug-testing schemes implemented by major corporations
actually increased fourfold. Id.
311. James Velasquez, Drug Testing in Schools: A Brief Review and Analysis of Recent Events,
41 AM. J. HEALTH EDUC. 180, 180 (2010). In 2003, 13% of United States middle and secondary
schools applied random drug-testing programs on their students; in 2006, this figure rose to 25.5%.
Id. (noting that drug testing policies vary widely among school districts across the country); see also
Paul J. Fudala et al., An Examination of Current and Proposed Drug-Testing Policies at US Colleges
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schemes in an academic environment, concerns center on the balance
between students’ privacy rights under the Fourth Amendment312 and
university administrators’ interests in preventing drug abuse and medicinal
cheating.313 Fourth Amendment protections are triggered when a state or a
state agent conducts the drug-testing search.314 Generally, courts consider
scholastic state actors to include publicly-funded colleges or universities.315
Therefore, drug testing at private universities may not require the same
Fourth Amendment scrutiny.316
For public universities317 to apply a constitutionally permissible drugtesting scheme, the drug testing must be (1) voluntary, (2) based on
reasonable suspicion, or (3) administered in a reasonable manner that
furthers an important governmental interest.318 Obtaining voluntary consent

and Universities, 42 J. AM. C. HEALTH 267, 267 (1994) (analyzing results from a national survey
encompassing 332 colleges that drug test their students).
312. The Fourth Amendment to the U.S. Constitution protects an individual’s right to be secure in
his person or effects against unreasonable searches and seizures. U.S. CONST. amend. IV.
313. Velasquez, supra note 311, at 180. Fourth Amendment analysis requires this balancing test
to determine if searches either are unreasonable or permissible under the special needs doctrine—a
doctrine “applied ‘only in those exceptional circumstances in which special needs, beyond the
normal need for law enforcement, make the [Fourth Amendment’s] warrant and probable-cause
requirement impracticable.’” Schieffelin, supra note 13, at 962–63.
314. Pavisian, supra note 42, at 185. Random searches by state actors traditionally required
probable cause, a search warrant, or both to satisfy Fourth Amendment reasonableness standards.
See Velasquez, supra note 311, at 181.
315. Pavisian, supra note 42, at 192; see also NCAA v. Tarkanian, 488 U.S. 179, 192 (1988)
(explaining that private parties perform state actions when “the State provide[s] a mantel of authority
that enhance[s] the power of the harm-causing individual actor[s]”).
316. See generally Private Law Schools, AM. BAR ASS’N, http://www.americanbar.org/groups/
legal_education/resources/aba_approved_law_schools/private_law_schools.html (last visited Mar. 3,
2012) (listing 117 private law schools); Private Medical Schools—Tuition and Fees First Year
Medical Students 2011–2012, ASS’N OF AM. MED. COLLS., http://services.aamc.org/tsfreports/
report.cfm?select_control=PRI&year_of_study=2012 (last visited Mar. 3, 2012) (listing fifty-four
private medical schools).
317. See generally Public Law Schools, AM. BAR ASS’N, http://www.americanbar.org/
groups/legal_education/resources/aba_approved_law_schools/public_law_schools.html (last visited
Mar. 3, 2012) (listing eighty-one public law schools); Public Medical Schools—Tuition and Fees
First Year Medical Students 2011–2012, ASS’N OF AM. MED. COLLS., http://services.aamc.org/
tsfreports/report.cfm?select_control=PUB&year_of_study=2012 (last visited Mar. 3, 2012) (listing
eighty public medical schools).
318. See Pavisian, supra note 42, at 201; Velasquez, supra note 311, at 184. Public middle and
secondary schools can perform drug testing through the doctrine of in loco parentis, which allows
“school officials [to] stand in place of parents/guardians in maintaining discipline, supervision, and
safety.” Velasquez, supra note 311, at 181. Graduate universities cannot use the in loco parentis
doctrine because their students typically are adults, which means they must apply the traditional
Fourth Amendment balancing test to justify random drug-testing searches. Pavisian, supra note 42,
at 189; see also supra note 313 and accompanying text.
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may be the simplest way to implement a legal drug-testing policy.319
Medical and law school admissions can include drug-testing consent forms
within their acceptance applications320 or even make these forms
prerequisites for participation in extracurricular activities—such as clinical
programs, journals, and moot court competitions.321
Suspicion-based drug testing enables school administrators to test
students who act in a manner that gives rise to the reasonable suspicion of
drug abuse.322 For example, in Pierce v. Smith,323 the Fifth Circuit upheld
the drug testing of a medical resident after she slapped a patient because the
Texas Tech University teaching hospital had written policies that provided
for drug testing when a medical student’s behavior was consistent with drug
use.324 In the same way, medical and law school administrators can
319. Pavisian, supra note 42, at 201. For example, numerous universities require student athletes
to sign drug-testing consent forms before they can participate in intercollegiate athletics. See, e.g.,
CHARLESTON S. UNIV., STUDENT-ATHLETE HANDBOOK 20–24 (2011), available at
http://csusports.athleticsite.net/SAHandbook.pdf; FLA. GULF COAST UNIV., STUDENT-ATHLETE
HANDBOOK 64–74 (2011), available at http://www.fgcuathletics.com/media/2011-12/Student%20
Athlete%20Handbook%201112.pdf; UNIV. OF TEX. STUDENT-ATHLETE MANUAL 49–53 (2011),
available at http://grfx.cstv.com/photos/schools/tex/genrel/auto_pdf/2011-12/misc_non_event/11acad-serv-student-manual.pdf.
320. See Pavisian, supra note 42, at 201 (noting that consent precludes students from asserting
Fourth Amendment claims). For example, Florida International University requires drug testing for
all applicants as a prerequisite to entering the first year of its medical school. Background Check
and Drug Testing, FLA. INT’L UNIV., http://medicine.fiu.edu/admissions.php?ss=back (last visited
Mar. 3, 2012). However, such a broad policy creates strong Fourth Amendment challenges that may
incentivize courts to strike this admissions procedure. See WILLIAM A. KAPLIN & BARBARA A. LEE,
THE LAW OF HIGHER EDUCATION: A COMPREHENSIVE GUIDE TO LEGAL IMPLICATIONS OF
ADMINISTRATIVE DECISION MAKING 267–68 (4th ed. 2006); see, e.g., Ga. Ass’n of Educators v.
Harris, 749 F. Supp. 1110, 1114 (N.D. Ga. 1990) (holding that the absence of a governmental
interest made a drug-testing scheme for all job applicants unconstitutional under the Fourth
Amendment balancing test). Instead, universities can seek voluntary consent from all incoming
applicants—but not as a prerequisite for enrollment. If an applicant opts out of the drug-testing
scheme, administrators can note this decision on a student’s transcript or file in a similar manner as
transcript asterisking. See infra notes 346–48 and accompanying text.
321. For example, Oregon Health and Science University requires all of its medical students who
participate in clinics and involve themselves with patient care to first go through a drug-screening
process. Medical Student Information Regarding Drug Testing, OR. HEALTH & SCI. UNIV.,
available at http://www.ohsu.edu/xd/education/schools/school-of-medicine/students/upload/DrugTesting-Information-4.pdf. Most universities also employ the “prerequisite scheme” with studentathletes. See supra note 319. For middle and secondary schools, courts have held that adolescent
students who participate in athletics or school-sponsored extracurricular activities have reduced
privacy rights and can be subjected to prerequisite consent forms. Velasquez, supra note 311, at
181–82; see also Bd. of Educ. of Indep. Sch. Dist. No. 92 v. Earls, 536 U.S. 822 (2002) (upholding
random drug testing for all students who participate in extracurricular activities); Vernonia Sch. Dist.
47J v. Acton, 515 U.S. 646 (1995) (upholding random drug testing for all student-athletes).
322. Velasquez, supra note 311, at 181 (“Reasonable suspicion may result from an eyewitness
account, a tip or information from a reliable source, suspicious behavior, drug or alcohol odor, or
behavior consistent with intoxication.”).
323. 117 F.3d 866 (5th Cir. 1997).
324. Id. at 882–83; see also KAPLIN & LEE, supra note 320, at 268 (noting that the nature of
medical students’ work means medical universities have special reasons to prevent drug abuse). For
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implement clear rules that require drug testing of their respective students
who exhibit the common signs of cognitive-enhancement drug abuse.325
If public universities do not obtain students’ consent or rely on
reasonable suspicion, they must establish that their drug testing policies
further sufficient governmental interests326 and are reasonably
administered.327 When drug-testing schemes apply to adults,328 courts
repeatedly have held that such warrantless searches are valid under the
Fourth Amendment if the governmental interests outweigh the individual’s
constitutional rights.329 In medical and law schools, randomized drug testing
targeted at medicinal cognitive-enhancement use furthers two governmental
interests: academic integrity330 and student safety.331 Courts have found both
concerns are valid state interests in Fourth Amendment analyses.332
Therefore, public universities can implement drug-testing schemes that will
pass constitutional muster if their applicable policies are also reasonably
administered.333
Reasonable administration considers the type of drug testing, the
procedures for the drug testing, and the policy of confidentiality.334

more information on drug-testing policies in the health-care sector, see Dana Devon, Drug Testing of
Health Care Workers: Toward a Coherent Hospital Policy, 23 AM. J.L. & MED. 399, 400–08 (1997).
325. See supra notes 131, 134, 137 and accompanying text (listing the common side effects for
different cognitive enhancers).
326. See supra note 318 and accompanying text.
327. For instance, in Colorado v. Derdeyn, the Colorado Supreme Court held that mandatory
drug testing for student-athletes, absent consent, was unconstitutional when the university failed to
(1) specify the method of administration and (2) provide advance notice. 863 P.2d 929, 949–50
(Colo. 1993).
328. Again, most medical and law school students are adults. See supra note 318.
329. See, e.g., Nat’l Treasury Emps. Union v. Von Raab, 489 U.S. 656, 679 (1989) (drug testing
U.S. Customs Service employees who dealt with drugs or possessed firearms); Skinner v. Ry. Labor
Execs’ Ass’n, 489 U.S. 602, 628, 634 (1989) (drug testing railroad employees involved in
accidents); Int’l Union v. Winters, 385 F.3d 1003, 1013 (6th Cir. 2004) (drug testing employees with
law enforcement powers); Dimeo v. Griffin, 943 F.2d 679, 685 (7th Cir. 1991) (drug testing
employees of the Illinois Racing Board); Int’l Bhd. of Teamsters, Chauffeurs, W. Conference of
Teamsters v. Dep’t of Transp., 932 F.2d 1292, 1304–05 (9th Cir. 1991) (drug testing drivers of
commercial vehicles).
330. See supra notes 285–87 and accompanying text.
331. See supra notes 131–81 and accompanying text.
332. See Pavisian, supra note 42, at 201–04 (providing an in-depth examination into courts’
opinions and common-sense arguments that support drug-testing policies based on safety and
academic integrity); see also Schieffelin, supra note 13, at 974 (noting that the government has a
“special need” to ensure a fair and safe educational environment).
333. See supra notes 326–27 and accompanying text.
334. Pavisian, supra note 42, at 205–06 (explaining that courts measure reasonableness by
weighing the proffered governmental interests with the testing intrusions).
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Administrators can test different samples—such as urine, hair, sweat, and
saliva—with varying degrees of intrusion.335 To avoid overly broad privacy
infringement, some universities may only check for cognitive enhancers, and
not for other illegal substances, to further the purpose of the medicinal
screening.336 Procedures for drug testing focus on whether the testing should
be randomly applied throughout the school year or predominantly
They also consider how
administered before or after exams.337
administrators should handle students with valid prescriptions—by either
giving them pre-exemptions338 or requiring them to prove valid use after
testing positive for cognitive-enhancer consumption.339 Lastly, drug testing
necessitates policies of confidentiality to protect students’ privacy rights.340
Inherent in privacy protection is the idea that positive drug-testing results
will not result in criminal penalties because schools will deal with testing
outcomes internally.341
While drug testing is a viable method to combat the overarching
problem of medicinal cognitive enhancement,342 school administrators may

335. Id. at 205. Pavisian recommends saliva testing as the most accurate, convenient, and least
intrusive method. Id. Hair and sweat samples, while less intrusive than urinalysis, create too many
false positives. Id. However, all types of drug testing are susceptible to error. Velasquez, supra
note 311, at 184. Therefore, universities may wish to implement subsequent follow-up tests to
combat the fears of flawed or inaccurate results. See id.
336. Schieffelin, supra note 13, at 976. Because student safety is one of the governmental
interests furthered by randomized drug testing, administrators may feel the need to also test for
illegal substances. See supra notes 331–32. However, this will implicate privacy concerns to a
larger extent, requiring the governmental interest to be even greater. See supra note 334.
337. Pavisian, supra note 42, at 206. Because medical and law school students consume
cognitive enhancers to improve their mental capabilities for final exams or papers, drug testing
during final exam periods makes more sense. See supra note 6 and accompanying text.
338. See Pavisian, supra note 42, at 206–07; Schieffelin, supra note 13, at 976. Administrators
should only give preexemptions to students who can prove their prescriptions are for FDA-approved
purposes, and not for off-label use. See supra note 69. For example, students who take Adderall for
AD/HD can receive medical exemptions in a similar manner as athletes under the NCAA or WADA
policies. Pavisian, supra note 42, at 206–07; see also supra note 309.
339. See Velasquez, supra note 311, at 184.
340. Pavisian, supra note 42, at 206.
Pavisian suggests that universities can ensure
confidentiality by replacing “student names with identification numbers to ensure that lab
technicians are blindly testing the samples” and by limiting “the group of people involved in
administering the tests, analyzing it, and reading the results.” Id.
341. Schieffelin, supra note 13, at 976; see also Velasquez, supra note 311, at 184 (stressing that
schools should not use drug testing to academically or legally punish student drug users). As one
commentator noted, courts probably are “more open to allowing a drug-testing scheme that does not
include jail time.” Pavisian, supra note 42, at 207. Because this drug testing is meant to catch
scholastic cheaters, university administrators have the discretion to determine appropriate academic
sanctions. Schieffelin, supra note 13, at 976.
342. Society has used drug testing to deter drug abuse since at least the 1960s, and, of course,
medicinal cognitive enhancement is a form of drug abuse. See supra notes 307–08 and
accompanying text.
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encounter other difficulties in its implementation—including expense,343
logistics, and potential liability.344 Specifically in the medical and law
school settings, drug screening serves to effectively negate the traditional
honor code framework that forms the “bedrock” of their educational
systems.345 Therefore, when weighing the pros and cons of drug-testing
policies, universities should also consider two other deterrence methods—
transcript asterisking and early preventative action.346
2. Transcript Asterisking
Transcript asterisking347 enables administrators to mark students’
transcripts with indiscrete asterisks to indicate grades may be a result of
cognitive-enhancer use—rather than solely talent or studious effort.348 An
asterisking policy will not reduce a grade;349 instead, it will warn potential

343. Expense is one of the biggest factors weighing against drug-testing policies, especially since
the cost “will ultimately rest with the university and the student body.” Pavisian, supra note 42, at
205. However, while urinalysis is expensive, other testing procedures are less expensive and
continue to drop in cost. See id.; Velasquez, supra note 311, at 184.
344. Fenton & Wunderlich, supra note 44, at 21. For a comparison of the advantages and
disadvantages of drug-testing schemes, see Griffin et al., supra note 307, at 470–71.
345. Fenton & Wunderlich, supra note 44, at 21; see also supra notes 22–23 and accompanying
text.
346. See supra note 298 and accompanying text.
347. An asterisk “is a star-shaped symbol used in writing to serve as a reference point.” Jody
Weisel, Asterisk is Not a Dirty Word, 37 MOTOCROSS ACTION MAG. 154, 154 (Feb. 2009). It
indicates “there is more to the story” than a record, statistic, or file reveals on its face. See id.
348. See Fenton & Wunderlich, supra note 44, at 21. This type of asterisk policy is commonly
found in sports. See, e.g., Karen Crouse, Swimming Bans High-Tech Suits, Ending an Era, N.Y.
TIMES (July 24, 2009), http://www.nytimes.com/2009/07/25/sports/25swim.html (considering
asterisks for athletes who wore swimsuits akin to “doping on a hanger”); Jere Longman, Track
Hears a Call to Wipe Out Records, N.Y. TIMES (July 18, 2004), http://www.nytimes.com/
2004/07/18/sports/track-and-field-track-hears-a-call-to-wipe-out-records.html?pagewanted=all&src=pm
(mentioning asterisks in international track and field annuals for drug use and faulty equipment);
Tom Verducci, Is Baseball in the Asterisk Era?, SPORTS ILLUSTRATED (Mar. 15, 2004),
http://sportsillustrated.cnn.com/vault/article/magazine/MAG1031393/index.htm (discussing asterisks
for steroid use). However, an asterisk essentially reflects disgust for cheating or alleged cheating in
any competitive setting, not just sports. Melinda Rosenberg, Nietzsche, Competition and Athletic
Ability, 2 SPORT, ETHICS & PHIL. 274, 283 (2008); see also supra notes 234–35 and accompanying
text (recognizing that medical and law schools are competitive environments).
349. Rules that reduce grades when disciplining students for nonacademic conduct may be illegal
depending on the jurisdiction. Gary Chartier, Truth-Telling, Incommensurability, and the Ethics of
Grading, 2003 BYU EDUC. & L.J. 37, 38. For instance, in Smith v. School City of Hobart, a federal
district court held that a school violated a student’s substantive due process rights when it reduced
her grade by twenty percent as punishment for alcohol-related misconduct. Smith v. Sch. City of
Hobart, 811 F. Supp. 391, 399 (N.D. Ind. 1993). However, courts also have taken the opposite
stance, such as the Texas Tenth District Court of Appeals that rejected the claim that “an academic

1043

DO NOT DELETE

4/20/2012 1:33 PM

employers350 that a grade may not “accurately reflect students’ abilities in
the subject matter taught.”351 Essentially, asterisking has two effects:
deterrence and exposure.352 “[I]t will deter those who understand that the
behavior is unethical; and it will expose those who don’t.”353
Transcript asterisking is an inexpensive and effective academic
sanction354 that universities can employ for different forms of scholastic
cheating.355 In terms of medicinal academic dishonesty, administrators can
mark student files and transcripts for brain-boosting use if students (1) are
caught taking cognitive enhancers356 or (2) test positive for cognitive

penalty for non-academic disciplinary purposes is constitutionally unreasonable and impermissible.”
New Braunfels Indep. Sch. Dist. v. Armke, 658 S.W.2d 330, 332 (Tex. App. 1983) (noting that the
grade reduction came from school suspension relating to alcohol use). The difficulty with medicinal
cognitive enhancement is that it is both nonacademic drug abuse and academic dishonesty. See
supra notes 303–06 and accompanying text.
350. It will also alert other graduate schools, certification boards, and bar examiners. See Fenton
& Wunderlich, supra note 44, at 21 (explaining that asterisking warns that a “student’s grade may be
more reflective of a chemical induction”).
351. Chartier, supra note 349, at 41. Grades should represent natural abilities and retained
knowledge:
A grade is accurate to the extent that it permits someone to estimate the extent of a
student’s knowledge and skills in a given area. It is inaccurate to the extent that it leads
someone to believe that she knows more or less than she does or that she can do more or
less than she can.
Id.; see also supra notes 211–13 and accompanying text. Grades should not represent artificially
acquired and transient capabilities. See supra notes 237, 241–42 and accompanying text.
352. Fenton & Wunderlich, supra note 44, at 21.
353. Id.
354. To compare asterisk policies with the expense of drug testing, see supra notes 343–44 and
accompanying text.
355. Many universities already use permanent transcript notations to punish academic dishonesty.
See, e.g., Academic Integrity and the Judiciary Process: Frequently Asked Questions—Students,
STONY BROOK UNIV., http://www.stonybrook.edu/uaa/academicjudiciary/faqistudent.shtml (last
visited Mar. 4, 2012); The Code for General Behavior and Citizenship Expectations, TUFTS UNIV.,
available at http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cts=13308
88437919&ved=0CDQQFjAA&url=http%3A%2F%2Fuss.tufts.edu%2Fstudentaffairs%2Fcodeofco
nduct%2Fgeneral_citizenship_expectations.doc&ei=jb1TT6uxC4LciAKMvrm0Bg&usg=AFQjCNH
84pWXcb5xiWjzVCUSsyonUhmgfg&sig2=hL2_Fe8BW8HRYT2SaT0qwg;
Undergraduate
Academic Ethics Board, JOHNS HOPKINS UNIV., http://www.jhu.edu/design/oliver/
academic_manual/ethics.html (last visited Mar. 4, 2012).
356. Professors or other students who discover cognitive-enhancement drug use can report it in
the same manner as any other form of academic cheating. See supra note 350 and accompanying
text. For example, professors or students can approach either university administrators or academic
honor boards. See supra notes 22–23, 355 and accompanying text. Accused students then have the
opportunity to refute the charges or prove valid prescription use. See supra notes 338–39 and
accompanying text. For examples of university honor codes, see The Medical Student Honor Code
for the University of Washinton School of Medicine, UNIV. OF WASH., available at
http://depts.washington.edu/honorsom/Honor_Code.pdf; Academic Honor Code: University of
California, Irvine—School of Law, UNIV. OF CAL., IRVINE, available at http://www.law.uci.edu/
current/ UCI_Law_Honor_Code.pdf.
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enhancers.357 For universities to validly facilitate asterisk procedures, they
also must implement early preventive actions that specifically acknowledge
that cognitive-enhancement drug use is an academic violation.358
3. Early Preventative Action
Because medical and law schools already require students to adhere to
honor codes, they can execute preventative actions within this ethical
framework.359 For example, they can include specific guidelines within
these codes that address medicinal cheating and its resulting sanctions.360
Additionally, orientations for first-year students can incorporate the signing
of honor statements that explain the ethics of cognitive-enhancement drug
use.361 Finally, mandatory professional responsibility and ethics courses362

357. See supra note 341 and accompanying text. If students opt out of voluntary drug-testing
programs, universities can also use asterisks to note their non-participation. See supra note 320 and
accompanying text.
358. See infra note 360 and accompanying text. “[T]here is something to be said of declaring the
conduct unethical in and of itself. To many, they may not consider taking [cognitive enhancers] a
form of cheating. [S]chools should take a firm stance and announce that the conduct is against the
rules.” Fenton & Wunderlich, supra note 44, at 21.
359. See supra notes 15, 22–23 and accompanying text.
360. See supra notes 303–06 and accompanying text; see also supra note 356 (listing examples of
university honor codes). If honor codes state that cognitive-enhancement drug use is a form of
academic dishonesty, then administrators will need to teach professors and honor board student
members how to detect signs of this scholastic cheating. See supra note 325 and accompanying text.
Most honor codes also require student witnesses to report violations or face their own possible
sanctions. See Justin Imperato, Trust Flourishes When Students Enforce Their Own Honor Code,
CHRISTIAN SCI. MONITOR, Nov. 7, 2000, at 15 (explaining the Statement of Non-Toleration); see
also supra note 23.
361. Fenton & Wunderlich, supra note 44, at 21–22 (“[O]nce people begin thinking about
honesty, they stop cheating completely; although, when you remove the benchmark of ethical
thought, they stray into dishonesty.”). Dan Ariely, the author of Predictably Irrational, explored
whether honor codes and professional oaths actually affected behavior: “He notes that occasional
swearing of oaths and statements of adherence of rules are not enough. Oaths and rules must be
recalled at, or just before, the moment of temptation. Students must be indoctrinated with honesty
early on.” Id. at 23; see also Tricia Bertram Gallant & Patrick Drinan, Organizational Theory and
Student Cheating: Explanation, Responses, and Strategies, 77 J. HIGHER EDUC. 839, 850 (2006)
(remarking that most researchers agree honor codes are not sufficient in and of themselves). During
high peak periods of potential cheating, such as finals weeks, schools can heed Ariely’s advice by
reminding students about the honor statements they previously signed. See David D. Wagaman &
Ibolya Balog, Reminders Work Wonders with Ethics, PA. CPA J., Winter 2011, at 1, 2. Furthermore,
exam procedures can require students to sign and submit statements that represent they have not
engaged in any form of academic cheating, including medicinal cognitive enhancement. Fenton &
Wunderlich, supra note 44, at 20 (discussing similar exam requirements for Loyola University
Chicago School of Law); see also Gary Pavela, Encouraging Students to Stop Cheating,
CURRICULUM REV., Jan. 1996, at 4, 4 (explaining exam procedures for the University of Maryland).
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can discuss the safety, legal, and ethical implications of brain boosting as
part of their curriculum.363 Even if instructors take just a day to address
cognitive-enhancement drug abuse, their discussions will give validity to the
scholastic problem and may engage the “moral imagination” of students in a
way that will encourage them to embrace the values of their prospective
professions.364
B. The Drug War: Recruitment of Professional Organizations
Besides university rules and honor codes, medical and law school
students must also study and work under the restrictions and regulations
imposed by their respective professional associations—including the AMA
and ABA.365 Both of these associations have rules against illicit substance
abuse and professional misconduct,366 but neither specifically tackles illegal
or legal cognitive-enhancer consumption for the sole purposes of academic
cheating.367
In the medical profession, students are especially vulnerable to
substance abuse because of their easy access to prescription medications.368
For example, one survey reported that senior medical students and
residents369 had a five to fifteen percent lifetime risk of developing a
chemical dependence.370 The AMA plays a key role in assisting medical
362. See supra notes 22–23 and accompanying text (explaining that medical and law school
students must take an ethics course within their respective curriculum); see also McCulley, supra
note 19, at 862 (suggesting the need for additional ethics education beyond one mandatory course).
363. See Fenton & Wunderlich, supra note 44, at 23 (noting that many educators find ethics
instruction sorely lacking). Universities rarely discuss the ethics of drug use. See Richard D. Aach
et al., Alcohol and Other Substance Abuse and Impairment Among Physicians in Residency
Training, 116 ANNALS INTERNAL MED. 245, 245–47 (1992). For example, most medical schools do
not provide educational programs on student drug abuse, do not have a formal system to address the
problem, and do not train faculty to recognize the problem. Id.; see also Barbara B. Blechner et al.,
The Jay Healey Technique: Teaching Law and Ethics to Medical and Dental Students, 20 AM. J.L. &
MED. 439, 440–42 (1994) (describing and recommending a needed law and ethics program).
364. See Fenton & Wunderlich, supra note 44, at 23; supra note 16 and accompanying text. As
one commentator aptly stated, “By implementing these suggestions, [medical and] law schools will
play a more active role in [medical and] legal professionalism.” McCulley, supra note 19, at 869.
365. See supra notes 17–18 and accompanying text.
366. See CODE OF MEDICAL ETHICS OP. 8.15 (1986) (addressing substance abuse among
doctors); MODEL CODE OF PROF’L CONDUCT R. 8.4(b) (2010) (discussing professional misconduct
among lawyers).
367. See supra note 366 and accompanying text.
368. Aach et al., supra note 363, at 245; see also Deborah Brooke et al., Addiction as an
Occupational Hazard: 144 Doctors with Drug and Alcohol Problems, 86 BRIT. J. ADDICTION 1011,
1011–12 (1991) (noting the same concern for physicians).
369. Medical residents are newly graduated medical students who are training in medical
residency programs. David C. Yao & Scott M. Wright, The Challenge of Problem Residents, 16 J.
GEN. INTERNAL MED. 486, 486 (2001).
370. Edward C. Halperin et al., Pre-Placement Screening of Resident Physicians by Substance
Abuse Testing: Efficacy, Cost, and Physician Opinions, 15 DRUGS: EDUC., PREVENTION & POL’Y
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students, residents, and physicians with their alcohol and drug-related
problems.371 The association even recommends drug testing for student
doctors and residents in certain health positions to further the “highest
traditions of the profession” because they have “voluntarily accepted
behavioral and ethical standards” that govern their vocation.372 In keeping
with this position, the AMA should adopt codes within the Principles of
Medical Ethics373 that clearly discourage both illegal and legal cognitiveenhancer consumption when utilized as a form of scholastic cheating.374
Because studies have found links between medical student burnout and the
propensity to cheat,375 the AMA can further its ethical regulations by
continuing to encourage “medical schools to establish relationships between
faculty members and students to promote a positive learning
environment.”376 Finally, the AMA can approve and support Continuing
Medical Education (CME)377 classes that discuss the ethics of cognitive-

77, 78 (2008) (noting that physicians have the same prevalent risk); see also Aach et al., supra note
363, at 246 (listing other surveys for medical students and residents-in-training with varying results).
371. See Aach et al., supra note 363, at 247.
372. Devon, supra note 324, at 411. The AMA also directly discourages student doctors from
self-prescribing or prescribing medications for their peers. See supra notes 122, 368 and
accompanying text.
373. See supra note 17 and accompanying text.
374. See infra notes 387–89 and accompanying text. The AMA already has a rule that addresses
substance abuse: “It is unethical for a physician to practice medicine while under the influence of a
controlled substance, alcohol, or other chemical agents which impair the ability to practice
medicine.” CODE OF MEDICAL ETHICS OP. 8.15 (1986). However, this Opinion does not recognize
cognitive-enhancer consumption as cheating. See supra note 367. The AMA can either (1) add a
comment to this Opinion that specifically states cognitive-enhancement use is a form of cheating, or
(2) adopt a new Opinion, such as “it is unethical for a medical student to practice or learn medicine
while under the influence of an illegal or legal cognitive enhancer when utilized for cheating
purposes.” See supra note 367.
375. See, e.g., Liselotte N. Dyrbye et al., Medical Student Distress: Causes, Consequences, and
Proposed Solutions, 80 MAYO CLINIC PROC. 1613, 1616 (2005) [hereinafter Medical Student
Distress]; Liselotte N. Dyrbye et al., Relationship Between Burnout and Professional Conduct and
Attitudes Among US Medical Students, 304 J. AM. MED. ASS’N 1173, 1176–77 (2010).
376. Medical Student Distress, supra note 375, at 1617–19 (listing other actions that the AMA
can suggest—such as implementing student-led support programs, identifying and assisting
struggling students, and teaching stress-coping skills).
377. CME are educational courses that physicians must take to earn their required annual credits
for continued certification. See supra note 25 and accompanying text. See generally Continuing
Medical Education, AM. MED. ASS’N, http://www.ama-assn.org/ama/pub/education-careers/
continuing-medical-education/cme-credit-offerings.page? (last visited Mar. 4, 2012) (describing the
importance of a physician’s continuing educational and professional development). For more
information on CME activities and the credit system, see The Physician’s Recognition Award and
Credit System: Information for Accredited Providers and Physicians, AM. MED. ASS’N, 1–5 (2010),
available at http://www.ama-assn.org/ama1/pub/upload/mm/455/pra-booklet.pdf.
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enhancement drug use and teach physicians how to detect such medicinal
abuse in their student doctors.378
In a similar vein as the AMA, the ABA needs to explicitly state in the
Model Rules of Professional Conduct379 that cognitive-enhancement drug
abuse is a form of dishonesty or deceit that constitutes professional
misconduct.380 Recognizing that medicinal brain boosting is an academic
violation will allow bar examiners to use the existing ABA framework for
evaluating the good moral character of legal applicants found guilty of such
cheating.381 This legal professional association, which requires active
lawyers to take Continuing Legal Education (CLE)382 classes in a manner
comparable to the AMA,383 can also promote and endorse courses that

378. See Yao & Wright, supra note 369, at 486–90 (explaining how residency program directors
and attending physicians can identify and handle problem residents); see also supra note 360 (noting
that medical and law schools also should teach professors and students how to recognize medicinal
cognitive enhancement). In a 2006 large-sample survey of health-care providers, respondents stated
that ethics-based CME classes were more likely to assist them with more effective client care. Mark
E. Johnson et al., The Need for Continuing Education in Ethics as Reported by Rural and Urban
Mental Health Care Providers, 37 PROF. PSYCHOL.: RES. & PRAC. 183, 184, 187 (2006).
Specifically, they asked for more classes dealing with the ethical management of clients with
substance abuse problems and the ethical issues of colleague misconduct. Id. at 187. The authors of
the study challenged continuing education providers “to offer ethics learning experiences that not
only provide critical information on key ethical issues, but also engage the learner by providing
information on timely and relevant topics that can be applied on a daily basis.” Id. at 188.
Education on cognitive-enhancement drug use fits these criteria because it is a growing, relevant
problem among medical students and physicians-in-training who provide health services and intern
under the doctors taking the CME classes. See supra notes 84, 372 and accompanying text.
379. See supra note 18 and accompanying text.
380. See McCulley, supra note 19, at 845. Generally, the Model Rules already warn that lawyers
will have to answer professionally for offenses of dishonesty and breach of trust. Id. at 845–46; see
also RONALD D. ROTUNDA, PROFESSIONAL RESPONSIBILITY 20 (3d ed. 1992) (“Conduct, whether or
not a crime, that involves dishonesty, fraud, deceit, or misrepresentation, is disciplinable.”).
Specifically, Rule 8.4(b) states, “It is professional misconduct for a lawyer to commit a criminal act
that reflects adversely on the lawyer’s honesty, trustworthiness or fitness as a lawyer in other
respects.” MODEL CODE OF PROF’L CONDUCT R. 8.4(b) (2010). While this Rule may encompass the
illegal consumption of cognitive enhancers, the ABA can definitively address cognitiveenhancement cheating by either (1) adding a comment to this Rule that specifically states that both
illegal and legal cognitive-enhancement cheating is professional misconduct, or (2) adopting a new
Rule, such as “it is professional misconduct for a law student to practice or learn law while under the
influence of an illegal or legal cognitive enhancer when utilized for cheating purposes.” See supra
note 374 (suggesting similar phrasing for an AMA proposed rule).
381. McCulley, supra note 19, at 846. Bar examiners already consider an applicant’s academic
violations in determining whether to certify the applicant for legal practice. Id. at 846, 849 (noting
that bar examiners also take an applicant’s suspected cheating and failure to disclose into account
when assessing good moral character).
382. ABA Model Rule for Continuing Legal Education and Comments, AM. BAR ASS’N, 1–2
(2004), available at http://www.americanbar.org/content/dam/aba/migrated/2011_build/cle/mcle/
aba_model_rule_cle.authcheckdam.pdf (explaining that lawyers must acquire twelve to fifteen credit
hours annually through CLE classes).
383. See supra note 377 and accompanying text.
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address medicinal brain boosting and its ethical implications.384 Lastly, the
ABA should encourage law school administrators, professors, and lawyers to
uphold its regulations against cognitive-enhancement drug abuse through
their own respective programs, rules, and reporting methods.385 Only with
the AMA and ABA’s official recognition and approval can medical and law
schools begin to effectively combat Generation Rx’s growing trend of
cognitive cheating.386
V. CONCLUSION
Cognitive enhancers improve the mental performance of the average
consumer and arguably are appropriate brain-boosting tools for the majority
of society.387 While numerous proponents lobby for general utilization of
these prescription medications,388 medicinal cognitive enhancement abuse is
not ethically appropriate in the higher-educational setting of medical and law
schools.389 Instead, such use is equivalent to academic cheating.390 Both
university administrators and professional organizations need to address this
growing trend of dishonesty before new, more potent memory drugs hit the
scholastic market.391 Further, the adoption of clear prohibitions against
cognitive-enhancement drug abuse will enable these respective parties to
monitor and prevent Generation Rx’s latest cheating technique.392

384. See supra note 378 and accompanying text. While medical students work with practicing
physicians in clinical programs, law students intern with lawyers through clinics and externships.
James Backman, Externships and New Lawyer Mentoring: The Practicing Lawyer’s Role in
Educating New Lawyers, 24 BYU J. PUB. L. 65, 65–66 (2009). Therefore, lawyers who recognize
the signs of cognitive-enhancer abuse will facilitate prevention in the same way as informed
physicians. See supra note 378 and accompanying text. For example, under the Model Rules,
lawyers who supply character references for bar applicants are discouraged from recommending
applicants who demonstrate behavior not in accord with good moral character. ROTUNDA, supra
note 380, at 29. If a lawyer discovers that a student is cognitively cheating, he should not
recommend that student for legal certification. Id. He also may “volunteer [this] unfavorable
information to the bar authorities about an applicant” to support “ethical aspiration[s].” Id. at 30; see
also MODEL CODE OF PROF’L CONDUCT R. 8.1 (2010).
385. See supra notes 306, 381, 384 and accompanying text.
386. See supra notes 374, 380 and accompanying text.
387. See supra notes 4–7, 124 and accompanying text.
388. See supra notes 10, 124, 281 and accompanying text.
389. See supra notes 282–86 and accompanying text.
390. See supra note 283 and accompanying text.
391. See Goodman, supra note 81, at 148–49; supra notes 287–90 and accompanying text.
392. See supra notes 360, 386 and accompanying text.
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